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Aims: The aim of this study was to investigate the approaches taken for dental 
assessment of patients with head and neck cancer (HNCa) by hospital dentists in New 
Zealand and Malaysia, in order to assist with the development of contemporary 
uniform guidelines for pre-radiation oral health management.  
 
Methods: A review of national guidelines was conducted from United Kingdom, United 
States, Australia, and New Zealand. A questionnaire-based survey of specialists and 
hospital dentists working in a hospital setting within New Zealand and Malaysia was 
undertaken. Information was collected about knowledge of the effects of radiotherapy 
on the oral environment, current practice regarding the dental management of HNCa 
patients prior to radiotherapy, guidelines practitioners were currently using and 
problems that they faced treating HNCa patients.  
 
Results: One hundred questionnaires were distributed; 50 for each country and the 
response rate was 75%. The respondents were consultants/specialist (34.7%), 
specialist registrars (8.0%), general dentists/ dental officers (38.7%), house surgeons/ 
first year dental officers (17.3%) and other (1.3%). The majority of respondents stated 
that multidisciplinary meetings (MDM) were held at their centre (New Zealand- 51.4%; 
Malaysia - 52.5%) but the health practitioners attending the MDM varied. Only 48.6% 
New Zealand and 2.5% Malaysian respondents followed formal guidelines or protocols 
for dental assessment of HNCa patients. Problems that were highlighted included late 
referral from the medical team, lack of radiation information and inadequate 
knowledge among the dentists themselves in managing these patients.  
 
Conclusion: This study highlights the need for developing clinical guidelines to support 
effective dental treatment and management strategies for this vulnerable population. 
Effective communication between health professionals and improved training could 
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Radiation therapy to the head and neck region can lead to various dental and orofacial 
complications such as mucositis, xerostomia, radiation-related dental caries, trismus 
and osteoradionecrosis. Multiple studies have been done with regards to delivery of 
optimum dosage and dosimetry of radiation. Advances in radiotherapy treatment aim 
to achieve a balance between therapeutic dosage while sparing as much normal tissue 
from irradiation as possible, thus reducing radiation-induced complications and 
allowing a better quality of life  (Bhide and Nutting, 2010). It is widely noted that three-
dimensional (3D) conformal radiation therapy and intensity-modulated radiotherapy 
(IMRT) are far superior compared to two-dimensional radiation therapy. Target volume 
and organs at risk can be demonstrated clearly in 3D while IMRT delivers a higher dose 
of radiation to the specific target area, sparing adjacent tissues and organs. However, 
despite advances in radiotherapy, long term irreversible damage to salivary glands, 
connective tissue, vasculature and bone is still present. Recommendations for dose 
limits to these organs to minimize the complications has been described by  Wang and 
Eisbruch (2016).   
 
Multidisciplinary team care is widely accepted as best practice for patients with HNCa. 
It can influence treatment decisions, improve cancer staging and outcomes, ensure 
consistent follow up and enable inclusion of allied health professionals in managing 
these patients holistically (Friedland et al., 2011). Dental treatments for patient that 
will be undergoing radiotherapy for HNCa are planned according to the intended 
radiotherapy treatment (dosimetry and commencement date),  co-morbidities, patient 
motivation on oral care, overall dental condition and the potential risk of 
osteoradionecrosis if dental treatments need to be done post-radiotherapy. It is really 
important to establish good communication between the cancer team and the dental 
team so information regarding cancer treatment can be aligned in accordance with the 
dental treatment plan. Through multidisciplinary meetings (MDM), communication 




A more proactive approach to reduce radiation-induced oral complications is by having 
dental assessment prior to radiotherapy treatment. Though it is recommended that 
HNCa patients have this assessment, there are many reasons why it does not always 
occur.  Lack of medical and dental clinicians’ awareness and limited time before 
commencement of radiotherapy hinder appropriate dental treatments. The 
International Society for Oral Oncology (ISOO) and the Multinational Association of 
Supportive Care in Cancer (MASCC) has stated the necessity of prevention and 
management of orodental complications of cancer patients. It is noted that untreated 
oral foci or dental problems that are not fully resolved before starting radiotherapy will 
increase the need for tooth extraction post-radiotherapy, thus increasing the risk of 
osteoradionecrosis (ORN) (Schuurhuis et al., 2011). Through prevention and effective 
early management of oral disease, radiotherapy treatment completion will be 
facilitated and emergency dental and medical treatment needs will be reduced.  
 
Research has been undertaken to seek the best evaluation tools and protocols for 
managing the dental needs of patients undergoing radiotherapy to the head and neck. 
Review of the literature has shown that there was not a specific evaluation tool that 
had been developed to aid efficient referral between radiation oncologists and 
dentists (Allard et al., 1993). Frequently, management is merely based on the 
clinician’s experience and opinions rather than evidence-based research (Jansma et al., 
1992; Ben-David et al., 2007). Variations in clinical guidelines for managing dental 
issues before radiotherapy among treatment centres have been addressed (Patel et 
al., 2012; Barker et al., 2005). It is prudent to identify the foci of oral disease in these 
patients, develop a systematic dental assessment and evidence-based protocols for 
dental management (Schuurhuis et al., 2015). 
 
Despite the advances in radiotherapy, pre-radiation dental assessment and 
multidisciplinary management of HNCa patients, the dental team is still facing a 
multitude of challenges. These challenges include the high number of patients lost to 
follow-up dental care, lack of an effective treatment for xerostomia, poor patient 
compliance and a lack of standardised guidelines. There is also a significant gap in the 
provision of oral and dental care such as the lack of guidelines or knowledge of 
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available guidelines and also the absence of integrated dental and medical services 
(Barker et al., 2005). 
 
HNCa patients usually were not provided with specialist dental care. Some of them 
sought treatment with their general dentists prior to radiotherapy while others did not 
receive any dental care at all (Epstein et al., 2007). Research has shown that good oral 
health is linked to better quality of life (Nuttall et al., 2001; Saub and Locker, 2006; 
Yiengprugsawan et al., 2011; Sönmez and Top, 2016; Masood et al., 2017), thus 
inclusion of the dental team in the management of HNCa patient before, during and 
after radiotherapy is crucial. Recent publications have attempted to define the role of 
a general dentist within the multidisciplinary team and to standardise oral care, in 
particular to highlight the importance of long-term regular support within the 
community and facilitate specialised care where necessary (Brody et al., 2013). Further 
investigation is required to evaluate the variety of guidelines that have been used and 
the dental management during pre-radiation dental assessment. Furthermore, by 
identifying the barriers that are faced by dentists in providing dental treatment for 
HNCa patients that will be undergoing radiotherapy, it is hoped that delivery of dental 
care can be enhanced. 
 
For this research, Malaysia and New Zealand were chosen for a comparison study 
because of the variation in incidence and aetiological factors for HNCa. No comparison 
study has been done previously with regards to this topic. A comparison study may be 
useful in determining factors contributing to the provision of dental care and for 
considering the multiple factors needed to deliver the best dental treatment and 
management such as local protocols, differences in healthcare system and also 
variances of treatment modalities. The choice of Malaysia and New Zealand was also 





2.  LITERATURE REVIEW 
 
2.1 Head and neck cancer 
 
Head and neck cancer is a broad group of lesions and includes all malignancies of the 
nasopharynx, nose and paranasal sinuses, larynx, oropharynx, hypopharynx, thyroid 
and salivary glands as well as the oral cavity and lips (Malaysian Society of 
Otorhinolaryngologists and Head & Neck Surgeons, 2012; National Head and Neck 
Cancer Tumour Standards Working Group, 2013; Cancer Society of New Zealand, 
2015). The recent World Health Organization classification of head and neck tumours 
grouped the lesions according to their location and with further sub-classification into 
the types of tumours (El-Naggar et al., 2017). Head and neck tumours are classified 
into:  
 
 Tumours of nasal cavity, paranasal sinus and base of skull 
 Tumours of the hypopharynx, larynx, trachea and parapharyngeal space 
 Tumours of the oral cavity and mobile tongue 
 Tumours of the oropharynx (base of tongue, tonsils, adenoids) 
 Tumours and tumour-like lesions of the neck and lymph nodes 
 Tumours of the salivary glands 
 Odontogenic and maxillofacial bone tumours 
 Tumours of the ear 
 Paraganglion tumours 
 
Worldwide, HNCa is the sixth most common type of cancer following lung, breast, 
colorectal, stomach and liver cancer and it is more common in developing countries 
(Warnakulasuriya, 2009; Ferlay et al., 2015). The male to female ratio ranges from 2:1 
to 4:1. About 90% of all head and neck cancers are squamous cell carcinomas (World 
Health Organisation, 2014). The risk of HNCa increases with age. Most of the HNCa 
cases occur in patients over 50 years old (Vigneswaran and Williams, 2014).  However, 
globally, experts noted that there has been an increase in HNCa cases among younger 
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adults (less than 45 years old) over the past 30 years and the tongue was the most 
common site for oral cancer (Majchrzak et al., 2014; Hussein et al., 2017). Differences 
in tobacco use, alcohol use, exposure to sunlight and habits such as the use of betel 
quid and sexual practices between countries contributed to a variation of HNCa trends 
worldwide (Simard et al., 2014). 
 
In Malaysia, head and neck cancer represents 11.6% of all cancers. This statistic is 
lower for New Zealand where only 3.5% of all cancers are HNCa (Ferlay et al., 2013). 
These statistics captured cancer of lip and oral cavity, nasopharynx, other pharyngeal, 
larynx and thyroid. The most common location for HNCa differs between Malaysia and 
New Zealand; nasopharynx (Malaysia) and lip and oral cavity (New Zealand).  In 
Malaysia the incidence of cancer of the nasopharynx was the highest among the 
Chinese compared to other ethnicities between 2007 up to 2011 (National Cancer 
Institute, 2015). As for New Zealand, oral squamous cell carcinoma (OSCC) mainly 
affected New Zealand Europeans (Gavidi et al., 2014).  However, HNCa incidence as a 
group was significantly higher in indigenous (Maori) men in New Zealand compared to 
their non-indigenous counterparts (Moore et al., 2015). The prognosis and survival of 
patients with HNCa is dependent on disease stage at presentation and the quality of 
care provided to each patient (Wong et al., 2015).  
 
The primary causes of HNCa are tobacco, alcohol use and Human Papilloma virus 
(HPV). The carcinogenic effect of tobacco is related to the smoking rate in packs per 
day and duration of smoking in years (“pack-years”) (Thompson, 2014). Tobacco use 
includes cigarette smoking, cigar and pipe smoking, reverse smoking and smokeless 
tobacco (chewing tobacco, moist or dry snuff). Cigar and pipe smoking increases the 
risk of lip cancer while hard palate cancer is related to reverse smoking (Vigneswaran 
and Williams, 2014). Smokeless tobacco causes high cancer prevalence involving the 
mandibular buccal sulcus and gingiva (Rodu and Jansson, 2004).   The combination of 
alcohol consumption and tobacco use increases the risk of HNCa because of its 
synergistic effect (Hashibe et al., 2007; Dal Maso et al., 2016). This is related to the 
conversion of ethanol into acetaldehyde, which is toxic and a known carcinogen (Xue 
et al., 2012). Alcohol will aid harmful tobacco chemicals into cells of the body and also 
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prevent repair of the damaged DNA caused by tobacco (National Cancer Institute, 
2013).   
 
Human Papilloma Virus infection has been linked to cancers of the oropharynx, tonsil 
and base of tongue in younger adults (Rettig and D’Souza, 2015). A systematic review 
and meta-analysis on the global prevalence and distribution of HPV in HNCa (HPV-
HNCa) showed that it was more prevalent in the oropharynx (45.8%) than 
larynx/hypopharynx (22.1%) and oral cavity (24.2%). 82.2% of all HPV-HNCa was 
caused by HPV16 (Ndiaye et al., 2014). Oral sexual behaviours are believed to be the 
primary mode of transmission of HPV to head and neck region (Rettig and D’Souza, 
2015). HPV-positive tumours have better responsiveness to radiation, chemotherapy, 
or both, and might be more susceptible to immune surveillance of tumour-specific 
antigens compared to HPV-negative tumours (Licitra et al., 2006). 
 
Other risk factors for HNCa are areca nut chewing, sun exposure, immune suppression 
secondary to solid organ transplant and Epstein-Barr virus for nasopharyngeal cancer. 
Lip cancers are associated with chronic sun exposure and ultraviolet light radiation 
(Warnakulasuriya, 2009). Many studies have reported a link between nasopharyngeal 
cancer with increased risks associated with certain foods such as salted fish, certain 
preserved foods and hot spices, all of which are high in carcinogenic nitroso 
compounds and volatile nitrosamines (Parkin et. al, 2011).  
 
 
2.2 Treatments for head and neck cancer 
 
Early detection of HNCa and advances in its management has led to somewhat better 
prognosis, but the associated morbidity and mortality remains high. The mortality rate 
was 6.6% for Malaysia and 2.3% for New Zealand (Ferlay et al., 2013). HNCa is 
classified according to the TNM staging system where T (tumour) describes the 
primary tumour size and invasion of nearby tissues, N (Lymph nodes) lymph node 
involvement while M is related to metastases to other sites. TNM provides a consistent 
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method of describing a tumour and linking this to its behaviour and malignancy. TNM 
is also useful for estimation of cancer prognosis and to determine the treatment 
modality (van der Schroeff and Baatenburg de Jong, 2009). Multiple factors contribute 
to the selection of treatment modalities such as differences in the availability and 
quality of oncology surgery, radiotherapy and medical oncology services, patient’s 
comorbidities as well as socioeconomic factors. 
 
HNCa treatments vary depending on the type of tumour, its location and TNM staging. 
Treatment planning is tailored specifically for each patient. Treatments can be 
radiotherapy, surgery, chemotherapy or a combination of these. Chemotherapy agents 
have evolved from drugs that caused systemic toxicity to specific molecular-targeted 
agents which can selectively kill cancer cells (Rao et al., 2012). Systemic therapy acts 
by non-specifically inhibiting cell replication. The drugs include cisplatin (induces DNA 
damage), fluorouracil (interferes with DNA replication) and taxanes (disrupts mitosis). 
Cetuximab, a monoclonal antibody which is an epidermal growth factor receptor 
(EGFR) inhibitor, is the only approved molecular-targeted therapy for use in HNCa. 
Research for others targeted agents mainly focused on the EGFR pathway (Rao et al., 
2012).  
 
In terms of radiotherapy treatment, options include external beam radiation, internal 
radiation (brachytherapy), intensity modulated radiation therapy (IMRT) and 
tomotherapy. IMRT is a technique of high-precision radiation therapy that uses 
computer-controlled linear accelerators (known as linacs) to deliver precise radiation 
doses that specifically target the tumour. IMRT allows for the radiation dose to shape 
precisely to the tumour by ‘modulating’ (varying) the intensity of the radiation beam. 
As a result, high radiation doses can be focused into the tumour while avoiding the 
surrounding normal body tissues as much as possible (The Royal Australian and New 
Zealand College of Radiologists, 2015). Various studies have concluded that IMRT 
seems to cause substantially less damage to normal tissue while providing equally 




Currently, external beam radiotherapy is the principal method of radiotherapy for 
head and neck cancer in Malaysia and brachytherapy is also available in a small 
number of centres. Besides external beam radiotherapy, IMRT is also available in many 
hospitals in Malaysia. However, there may still be linear accelerators which are not 
capable of carrying out IMRT (Malaysian Oncological Society, 2015). In New Zealand, 
three-dimensional conformal radiotherapy is the minimum requirement for radical 
radiotherapy plans. IMRT is the principal method for HNCa treatment in New Zealand. 
If a centre does not have an IMRT program, the patients will be referred to another 
centre for IMRT treatment (National Head and Neck Cancer Tumour Standards 
Working Group, 2013). 
 
 
2.3 Multidisciplinary team in management of head and neck cancer 
patients 
 
Multidisciplinary care is important in providing the best-practice treatment and care 
for patients with HNCa (Kelly et al., 2013). Effective multidisciplinary treatment 
planning meetings will improve continuity of care, coordination of services, 
communication between care providers, allow more efficient use of time and 
resources and ultimately improve patient outcomes. This multidisciplinary care is 
provided by various clinicians. Some of the examples of the health 
professionals/services that are involved or may have access to attend MDM are as 
listed (Table 1). It may not portray the practice of all centres in that particular country. 
Documented information for Malaysia was unavailable. The members of MDM 
constitute both core members who will attend all meetings and associate team 
members who may attend upon referral for specific cases. Generally, core members of 
MDM should comprise of radiation oncologist, otolaryngologist/head and neck 
surgeon, plastic and reconstructive surgeon, maxillofacial surgeon, radiologist, 
pathologist, dentist, dietician, clinical specialist nurse and head and neck cancer 




Table 1 Involvement of multiple health practitioners in MDM according to national 
guidelines 
 
Country and author Health practitioners involved 
 
United Kingdom 




Surgeons (Otorhinolaryngology (ORL), maxillofacial, or 
plastic surgeons), clinical oncologists, restorative dentists, 
pathologists, radiologists, clinical nurse specialists, speech 
and language therapist, senior nursing staff from the head 
and neck ward, palliative care specialists (doctor or nurse), 
dietitians, team secretary, data manager, multidisciplinary 








Head and neck surgery, radiation oncology, medical 
oncology, plastic and reconstructive surgery, specialized 
nursing care, dentistry/prosthodontics, physical medicine 
and rehabilitation, speech and swallowing therapy, clinical 
social worker, clinical nutrition, pathology, diagnostic 
radiology, adjunctive services (neurosurgery, 
ophthalmology, psychiatry, audiology, palliative care) and 







Care coordinator (as determined by multidisciplinary team 
members), clinical trials coordinator, dietitian, general 
practitioner, head and neck surgeon, medical oncologist, 
nuclear medicine physician, nurse (with appropriate 
expertise), occupational therapist, oral and maxillofacial 
surgeon, palliative care specialist, pathologist, pharmacist, 
physiotherapist, plastic and reconstructive surgeon,  
psychiatrist, psycho-oncology, radiation oncologist,  
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radiation therapist, radiologist/imaging specialists, social 
worker, special needs dentist, speech pathologist 
 
New Zealand 
(National Head and 




Otolaryngologist/head and neck surgeon, plastic and 
reconstructive surgeon, maxillofacial surgeon,  
maxillofacial prosthodontist, oral health consultant, 
radiation oncologist, medical oncologist, clinical nurse 
specialist, head and neck cancer coordinator, speech-
language therapist, dietitian, pain specialist, psychologist, 
palliative care specialist, radiologist with expertise in head 
and neck oncology, pathologist with expertise in head and 
neck oncology, gastrostomy services, neurosurgeon, 
adolescent and young adult key worker. 
 
Dental management should be considered as part of overall cancer management 
especially if patients are at risk of developing oral complications such as mucositis, dry 
mouth and radiation-related dental caries from cancer treatment. Multidisciplinary 
meeting (MDM) is the best platform to address these issues. The outcome of dental 
management is enhanced when there is an understanding of the inter-relationship 
between the oral and medical conditions, good interdisciplinary communication 
through integrated record keeping and optimal service provision facilitated by the 
utilization of evidence-based guidelines (Barker et al., 2005). Also, with good 
communication between the multidisciplinary management team, rapid delivery of 
dental care such as extractions may be able to be achieved if enough notice is given, 
appropriate resources are available and the hospital management has adequate 
prioritisation for this activity. Information such as the names of the surgeon and 
oncologists, diagnosis of cancer, TNM staging, cancer prognosis, date of 
commencement for radiotherapy treatment, types of treatment such as chemo-
radiotherapy and radiotherapy (IMRT, external beam) and dosimetry of the 
radiotherapy treatment (total cumulative dose, fractions and field of direct 
radiotherapy)  are needed from the MDM team to help with the dental treatment 
planning for these patients (Ray-Chaudhuri et al., 2013). This information will 
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determine the types of dental treatment that are suitable for the patient such as 
extraction versus conservative management (restoration or periodontal treatment), 
the risk of osteoradionecrosis in relation to extractions if the radiotherapy treatment 
begins in less than 14 days, prognosis of retained teeth and retention of removable 
prosthesis due to dry mouth in relation with high radiation doses.  
 
Kelly et. al (2013) compared care patterns before and after the introduction of MDT 
model for management of head and neck cancer patients. Pre-treatment dental 
assessment was one of the clinical quality indicators for evaluating the process of 
patient treatment. Other clinical quality indicators were pre-treatment nutritional 
assessments, Positron Emission Tomography (PET) staging where indicated, chemo-
radiation treatment referrals for stage III and IV disease, as well as for post-operative 
positive margins or extra capsular spread and the time interval from surgery to the 
start of radiation treatment. They noted that patients in the post-MDT group had 
higher rates of dental assessment and improvement in other areas such as nutritional 
assessment, PET staging and chemo-radiation referrals and shorter time from surgery 
to radiotherapy treatment. Overall, delays between diagnosis and multimodality 
treatment could be kept to a minimum, suggestive of enhanced efficiency which is 
mainly contributed by effective communication within the MDT. 
 
 
2.4  Side effects of radiotherapy on oral environment 
 
Advances in radiotherapy treatment have seen improvement in tumour control and 
survival rates. The incidence and severity of radiotherapy-related side effects 
compared to previous radiotherapy modalities has reduced but, currently, there is not 
one mode of radiotherapy that manages to successfully eliminate all the side effects. 
Radiotherapy for HNCa can induce devastating side effects both immediate and in the 
longer term. Post-radiation oral and dental sequelae are significant, well-known and 
can result in needless morbidity (Beumer et. al, 1983). Radiotherapy-related side 
effects include mucositis, candidiasis, alteration of taste, hyposalivation, radiation-
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related caries, increased risk of periodontal disease, trismus and osteoradionecrosis 
(ORN) (Vissink et al., 2003; Sciubba and Goldenberg, 2006; Jawad et al., 2015). Damage 
to the oral mucosa is strongly related to radiation dose, fraction size, volume of 
irradiated tissue, fractionation scheme and type of ionizing irradiation (Scully and 
Epstein, 1996). Management of these complications is problematic and they can add 
an additional burden to patients who are already battling cancer. Pre-existing oral and 
dental disease and poor oral care during and after cancer treatment are considered 
important risk factors for side effects of radiotherapy to the oral region. These patients 
will always remain as a high risk group for caries, oral infection and functional 
impairment following radiotherapy (Brody et. al, 2013).  
 
Oral mucositis, which is inflammation of the oral mucosa, is the most common 
complication and affects around 80% of head and neck radiotherapy treatment (HNRT) 
patients (Brown and Yoder, 2002). Its clinical presentations range from mild up to 
severe such as pain, ulceration, bleeding, infections and difficulty in feeding.  Mucositis 
can also become so severe that eating and drinking is not possible, such that the 
patient requires parenteral nutrition and may have to temporarily stop cancer 
treatment to allow recovery. Cancer therapy leads to damaged mucosa and reduced 
immunity which can have effect on the patient’s quality of life and make them more 
susceptible towards candida infection or septicaemia. Mucositis may occur during the 
second or third week of radiation therapy. It will gradually subside within two or three 
weeks of completing treatment (Lalla et al., 2014).  
 
Saliva is important for daily functions such as speaking, eating, swallowing, taste, 
denture retention and prevention of oral diseases (caries, periodontal diseases and 
candidiasis). Impaired salivary output will affect these functions, which can lead to 
malnutrition, weight loss and reduced quality of life. Involvement of salivary glands in 
radiotherapy treatment causes xerostomia (subjective feeling of dry mouth) and/or 
hyposalivation (low salivary flow rate). The normal unstimulated salivary flow rate is 
0.3-0.5 ml/minute. The consistency of saliva may change such as thin secretions with 
neutral pH or it may become more viscous with altered salivary pH, electrolyte and 
immunoglobulin content. Plaque also became more sticky and difficult to remove. The 
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parotid glands produce 60-70% of stimulated saliva while submandibular, sublingual 
and numerous minor salivary glands primarily produce unstimulated saliva (Dawes and 
Wood, 1973). Secretions from the parotid glands are serous while other salivary glands 
produce mucous secretions. Sparing at least one parotid gland so that it receives a 
mean dose of less than 20 Gy or ensuring that both glands receive a mean dose of less 
than 25 Gy tends to avoid severe xerostomia. Confining the submandibular glands to a 
mean dose of <35 Gy also reduces xerostomia symptoms (Deasy et al., 2010). 
Hyposalivation and trimus usually improve months after radiotherapy finishes, but 
may not return to normal.  Salivary gland function will steadily recover from 6 months 
up to 2 years after HNRT, provided that the damage is not too severe (Eisbruch et al., 
2001; Blanco et al., 2005). 
 
Radiation-related caries can develop within three months of the completion of 
radiation. The effect of irradiation on teeth can be direct or indirect. Hypotheses 
regarding the cause of radiation-related caries include a combination of direct 
radiation damage to the dentition, reduction in the quantity and quality of saliva, 
changes in taste perception leading to consumption of highly flavoured, possibly 
sweetened foods, changes in nutritional status requiring consumption of highly 
calorific foods and changes to the oral microbiota (Jawad et al., 2015). It was 
postulated that radiotherapy causes disruption of  pulpal collagen and degeneration of 
odontoblast processes which leads to fragility at the amelodentinal junction (Jawad et 
al., 2015). Rapid decalcification is related to the imbalance of organic and inorganic 
components of the teeth, in conjunction with intense acid attack. Radiation-related 
caries usually presents as decay around the tooth neck which can lead to complete 
amputation of the crown of the tooth. 
 
The risk of ORN is related to the dosage and location of radiation; high (more than 60 
Gy), moderate (between 40 to 60 Gy) and low (below 40Gy) (Gourmet and Chaux-
Bodard, 2002). The mandible is at more risk of developing ORN than the maxilla and 
the posterior segment is more at risk compared to the anterior segment possibly 
because the mandible and posterior region has lower blood supply compared to the 
maxilla and the anterior segment (Thariat et al., 2010). A study done by Thariat and 
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colleagues (2012) suggested the use of Dentalmaps as a guide to dental care of IMRT 
patients. It is an automatic atlas-based segmentation framework of the dental 
structures based on Computed Tomography (CT) images. It provides a reliable dental 
dosimetry for the maxilla, mandible and for each individual tooth. This information can 
be used to assess the risk of ORN more accurately if extraction is indicated. 
Dentalmaps represents a useful documentation and communication tool between 
radiation oncologists and dentists. A simple approach is to incorporate  the risk-
adapted dental care (RaDC) which is a form used for marking individual risk areas for 
dental treatment on the mandible and maxilla (Studer et al., 2011). It requires the 
radiation oncologists to topographically define ORN risk areas prior to dental 
treatment. The areas will be marked as low, intermediate or high risk. It will help with 
dental treatment planning so comprehensive treatments in high-risk areas can be 
undertaken in comparison to a less invasive approach in the regions that will receive 
lower doses of radiation. 
 
Surgery and radiotherapy can cause trismus because both may affect 
temporomandibular joints and the muscles of mastication particularly the masseter 
and pterygoid muscles. Trismus can cause persisting problems with pain, chewing and 
eating. A recent systematic review revealed that the prevalence of trismus was 25.4% 
for conventional radiotherapy and 5% for IMRT (Bensadoun et al., 2010).  
 
 
2.5 Pre-radiation dental assessment 
 
It is widely noted that older adults are now are retaining more teeth compared to 
many previous generations (Burt and Eklund, 1999; Ministry of Health New Zealand, 
2010; Thomson, 2012). It is more apparent in developed countries compared to 
developing countries where the rate of edentulism is still increasing because painful 
teeth are often extracted, rather than treated conservatively (Petersen and 
Yamamoto, 2005). The rate of edentulism also tends to vary among different regions 
or within a country (Wu et al., 2013; Hewlett et al., 2015; Olofsson et al., 2017). 
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Edentulism is closely associated with socioeconomic psychological and health-related 
factors. It is more prevalent in poor populations and in women. Other contributing 
factors include age, education background, access to dental care, dentist/population 
ratios, and insurance coverage (Islas-Granillo et al., 2011). 
This leads to the connotation that more teeth equal more problems for these people. 
It is one of the reasons that led to recognition of the importance of pre-radiation 
dental assessment in an attempt to reduce oral complications post-radiotherapy. 
Between 68% to 97% of patients examined prior to radiotherapy needed immediate 
dental care (Lockhart and Clark, 1994). A study on the oral health status of 207 HNCa 
cancer patients before, during and after radiotherapy in Brazil showed that 58% 
required dental treatment on first assessment and around 50% of the patients 
needed at least one extraction before radiotherapy (Jham et al., 2008). A cross-
sectional study on oral health status of HNCa patients treated at an Austrian tertiary 
hospital noted that around 90% out of 48 patients had large treatment needs due to 
caries and periodontal disease (Bertl et al., 2016). Around 50% of these patients 
mentioned that that they did not consult a dentist after cancer diagnosis. Dental 
management of HNCa patients is often complicated because they are more likely to 
have a high burden of dental disease, poor compliance with recommended treatment 
and low socioeconomic status (Lockhart and Clark, 1994). 
 
In centres with well organised multidisciplinary care, patients that are about to 
undergo radiotherapy are likely to be referred to a dentist, usually hospital-based, for 
assessment of their dental condition prior to treatment. Pre-radiation dental 
assessment aims to identify and manage oral foci such as carious teeth, periodontal 
diseases, impacted teeth and radiographic abnormalities, in an attempt to reduce or 
prevent oral complications related to radiotherapy treatment (Figure 1 and Table 2) 
(Schuurhuis et al., 2015; Buglione, Cavagnini, Di Rosario, Maddalo, et al., 2016). Other 
management include preventive treatment and fabrication of radiation stent to 
minimize mucositis by reducing back scatter of metal dental restorations (Ben-David et 




Figure 1 Significant oral foci that should be effectively eliminated or treated before 
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Table 2 Types of dental treatment provided prior to head and neck radiotherapy 









 Loose contact points should be repaired to prevent food and plaque 
impaction, thus reducing the chance of periodontal disease and 
dental caries 
 Sharp dental cusps or anything that might cause intra-oral trauma 
should be removed (to minimize mucosal injury during  
radiotherapy) 
 Resin-modified GIC, composite resin, and amalgam restorations 





a) Dental risk factors: 
 Primary and secondary deep caries (non-reparable) 
 Root caries > 1/2 of root circumference 
 Pulpal disease and periapical disease (avital pulps and no previous 
root canal treatment) 
 Periapical osteitis > 3 mm  
 Internal/external root resorption 
 Periodontal disease (probing depth > 6 mm, gingival recession > 6 
mm, spontaneous gingival bleeding, furcation involvement, mobility 
> 2 mm)  
 Non-functional teeth (partially impacted teeth, residual root tips, 
fully impacted teeth with pericoronal radiolucencies)  
 Poor oral hygiene  
 Low dental awareness.  
 Lack of cooperation 
 
b) Malignancy/ treatment-related risk factors:  
 Radiation dose > 55 Gy  
 Radiation field includes mandible and molar teeth 
 Teeth in close proximity to tumour  
 Time to radiotherapy < 14 days  




Thorough history taking such as documentation of current complaints, medical co-
morbidities, dental and social history, in conjunction with extra-oral and intra-oral 
baseline examination and radiographic assessment is crucial. It is recommended to 
take at least a panoramic radiograph. Additional radiographs such as bitewings and 
periapical radiographs are only done when indicated (Schuurhuis et al., 2015). Dental 
management during these assessments includes preventative measures, discussion 
about complications of radiotherapy affecting oral tissues and extraction of 
problematic teeth to allow healing prior to radiotherapy. Scaling and restorations can 
be done if time and circumstances permit or they can be postponed until radiotherapy 
treatment is finished. Preventative measures include smoking cessation advice, diet 
and sugar control, effective oral hygiene care and fluoride therapy such as high 
fluoride toothpaste and fluoride trays. Radiation stents are custom-made devices that 
displace or shield tissues. The stents are usually fabricated by the dental team. They do 
not prevent radiotherapy-related oral complications but they can reduce the incidence 
and severity of mucositis and xerostomia. Other types of aids that are used for the 
protection of healthy tissues include intra-oral shields used in the treatment of lip 
cancers and positioning masks for patient immobilisation during radiotherapy delivery 
(Figure 2) (Brody et al., 2013; Matsuzaki et al., 2017). 
 
Sometimes, pre-radiation dental assessment can be a difficult dental appointment for 
both patient and dentist. It is understandable that since the patient has just recently 
been given the news of the cancer diagnosis they might not engage during dental 
consultations. A patient who does not have any dental problems, may not want or see 
the need for dental treatment in light of their cancer diagnosis. Cost of the dental care 
might also be an issue. Patients should be advised about the reason they have to be 
seen by a dentist before their radiotherapy as it might seem unrelated to their main 
diagnosis. Making sure that patients understand the importance of dental care is an 
integral part of the pre-radiation work-up and it is useful if they accept that frequent 
recalls are likely to help with their oral health. Advice regarding continuation of follow-
up treatment post-radiotherapy is also important. Post-radiotherapy follow-up allows 
management of dry mouth, reinforcement of preventive programs and early 
intervention to detect and treat caries. Thus, it is recommended to deliver clear, 
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concise information, directed partly at any carer and reinforced with written 
information and a summary letter (Ray-Chaudhuri et al., 2013). Patients can also be 
directed to online resources and support groups.   
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Figure 2 Dental management of head and neck cancer patients receiving radiotherapy treatment (Adapted from Walker et al., 2011; Brody et al., 2013) 
 
Dental management 
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Professional cleaning
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decay: appropriate restoration
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Management of dry 
mouth and radiation 
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Extractions: Avoid if possible, 
atraumatic extractions
Monitor suspicious oral lesions 
Factors to consider: 
 Past medical history 
 Past dental history 
 Socioeconomic factors 
 Care and support 
 Access to care 
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2.6 Barriers to providing dental care 
 
Previous research has shown that there are multiple barriers faced by clinicians in 
order to provide dental care before the commencement of radiotherapy. Dental care 
providers noted there was often little time between initial dental consultation and the 
start of radiation, potentially leading to sub-optimal pre-radiotherapy dental 
treatment (Patel et al., 2012). Late referrals happened because oral care management 
may have been overlooked by the oncology or medical team. This highlights the need 
to educate the radiation oncologists regarding the importance of dental assessment 
for these patients to benefit and improve patient’s pathway of care and the 
importance of dental involvement in multidisciplinary planning groups. Apart from 
that, there is the possibility of diagnosis in very advanced stages, when radiotherapy 
has to be commenced rather urgently, thus affecting timely referrals to the dentists. 
 
A further barrier to providing dental care is illustrated by multiple studies that have 
noted the lack of knowledge among dental students and dentists to assess, identify 
and manage dental problems related to cancer therapy for head and neck cancer 
(Güneri et al., 2008; Alpöz et al., 2013).  
 
There is also a lack of internationally accepted protocols on managing the dental needs 
of HNCa patients undergoing radiotherapy. This leads to a variety of treatment 
decisions which may complicates the improvement of knowledge in relation to the 




2.7 Knowledge and practice of dentists and radiation oncologists 
 
Head and neck cancer patients that will be undergoing radiotherapy need a dental 
treatment plan formulated by their dentist and/or dental specialist, who have taken 
into consideration the advice and information given by the radiation oncologist and 
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other medical specialists. It will facilitate optimal oral health, minimise potential 
complications and coordinate dental and medical care. Management complexity varies 
on a case by case basis. Dental care may have to be provided by the patient’s dentist 
who may be practising remote from the main centre, with advice from the main 
oncology specialist team (Joshi, 2010).  
 
Several studies have investigated knowledge of HNCa therapy complications and 
management among dental students, dentists and even radiation oncologists (Güneri 
et al., 2008; Patel et al., 2012; Alpöz et al., 2013). They noted that the respondents had 
basic knowledge of the complications of cancer therapy, but failed to answer questions 
about required clinical practices. A study by Patel et. al (2012) indicated that there was 
a need for continuing education for dentists and radiation oncologists on clinical 
guidelines for effective oral and dental management of patients receiving radiotherapy 
to the head and neck region. 55% of dental respondents reported that they considered 
they were not adequately trained at dental school to treat patients who will or have 
had head and neck radiotherapy. 25% of radiation oncologists reported inadequate 
preparation to treat patients with oral health complications due to HNRT. 
 
Continuing education alone may not be sufficient to enable dentists to be confident 
and clinically competent to treat post-radiotherapy patients in clinical practice. 
Multiple literature reviews have recommended re-evaluation of current 
undergraduate curricula and organization of postgraduate courses to incorporate the 
dental management of oncology patients pre-, peri- and post-radiotherapy (Güneri et 
al., 2008; Alpöz et al., 2013).  Continuous education for dentists and radiation 
oncologists regarding the dental management of these patients is also beneficial (Patel 
et. al 2012; Alpoz et. al 2013).  
  
 
2.8 Protocols and guidelines  
 
Pre-radiation dental decisions are often very challenging (Bruins et. al, 1999), but 
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careful dental review and treatment helps the patient during their radiotherapy course 
and particularly has an impact post-radiotherapy. The decision to either extract or 
restore a tooth with a questionable prognosis is often challenging considering there 
are no clear guidelines. It will depend on the status of the tooth and the rest of the 
dentition, patient factors and choices, radiotherapy dosimetry and the clinicians’ own 
expertise and preference regarding mode of treatment (The Royal College of Surgeons 
of England / The British Society for Disability and Oral Health, 2012; Dewan et al., 
2014). 
 
Worldwide, there are multiple national and local hospital guidelines available with 
general recommendations for the management of the oral health of HNCa patients but 
there is inconsistency of the recommendations when these guidelines were compared.  
These guidelines and recommendations include those by Jansma (1992), Shaw (2000) 
and Grotz (2003), but such policies are based on experience and opinions rather than 
evidence-based clinical guidelines. It is recommended that a consensus statement 
about the medical necessity of oral and dental care, before, during, and after cancer 
therapy should be developed and guidelines established (Epstein et al., 2004).  
 
The Royal College of Surgeons of England / The British Society for Disability and Oral 
Health have developed a national guideline specific for the management of oral 
conditions in oncology patients requiring radiotherapy, chemotherapy and/or bone 
marrow transplantation (Table 3). It is quite comprehensive and detailed with inclusion 
of an oral health care screening chart and a patient information leaflet. They noted 
that there is no universally accepted pre-cancer therapy dental protocol because of the 
lack of clinical trials evaluating the efficacy of a specific protocol. The guideline from 
the National Comprehensive Cancer Network (USA) is user friendly and also detailed 
the needed dental care before, during and after cancer treatment. Detailed definition 
of teeth that need to be extracted was not provided in either guideline. Other national 
guidelines mentioned in Table 3 are management of head and neck cancer (Australia 
and New Zealand) and nasopharyngeal cancer (Malaysia). Worldwide, dental 
recommendations were general and only comprised a small fraction of the guidelines. 
In Malaysia, dental care was minimally mentioned in the Clinical Practice Guideline for 
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management of nasopharyngeal carcinoma. The guidelines noted that it is essential 
that nasopharyngeal patients received dental assessment prior to radiotherapy to 
minimise post-treatment oral complications, but there was no retrievable evidence on 
specific dental management (Malaysia Health Technology Assessment Section, 2016). 
In New Zealand, Standards of Service Provision for Head and Neck Cancer Patients also 
mentioned that patients receiving cancer treatment that involves or affects the oral 
cavity should be seen by an oral health consultant prior to treatment. There were only 
general recommendations, such as the need for appropriate chair, lighting and 
equipment for assessment and advice that extractions should be completed more than 
14 days prior to commencement of radiotherapy. In fact, comprehensive dental 
management includes taking radiographs, eliminating potential oral infection, 
optimising oral hygiene and formulating an initial plan for future oral and maxillofacial 




Table 3 National guidelines available in relation to dental management for head and neck cancer patients having radiotherapy
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A model for dental decision support (MDDS) was proposed by Bruins et. al (1999) to 
contribute to the development and analysis of guidelines and also to act as a training 
tool. A comprehensive oral health and panoramic radiograph evaluation tool for 
standardized data collection of HNCa patients has been developed, but it is still in the 
validation process (Jackson et al., 2015). These tools can be used for systematic 
collection of information relating to long-term oral clinical/radiographical 
complications, prevalence, and severity. They were said to be user-friendly and to 
provide a comprehensive, reproducible and inexpensive means to evaluate post-
therapy oral health of HNCa patients (Jackson et al., 2015). The tool developed by 
Jackson et. al enhanced/expanded the original tool develop by Bruins et. al and was 
more comprehensive due to the inclusion of oral and radiology section. 
 
Multiple specific forms have been constructed to help with efficient referral between 
radiation oncologist and the dentist, but they were not widely used. Studer et. al 
(2011) proposed risk-adapted dental care (RaDC) prior to IMRT. The RaDC requires 
radiation oncologists to topographically define mandibular ORN risk areas as high, 
intermediate and low (according to the radiation dosage) prior to dental treatment 
using a particular form. Thus, robust dental treatment can be performed in high risk 
areas and less invasive work in the regions that will receive lower doses of treatment. 
In general, there will be reduced swelling and faster tissue healing due to the less 
aggressive dental treatment. Thus, radiotherapy can be done sooner after dental 
treatment is finished. 
 
Evaluation tools such as Oral Health Evaluation Tool (OHET) and Panoramic Radiograph 
Evaluation Tool (PRET) have been developed to ensure assessment of all relevant oral 
health issues. They can also be used to collect information for research.  This tool can 
be incorporated for use in clinical trials, clinical databases and routine dental care. The 
Oral Health Evaluation Tool (OHET) is a systematic assessment of dental health with 
emphasis on oral health outcomes common to HNCa patients. Panoramic Radiograph 
Evaluation Tool (PRET) records clinically significant oral health outcomes assessable by 
panoramic radiography. Discrepancies could be based on a single patient (ORN), a 
single tooth (impaction), or single quadrant (periodontal bone loss) (Jackson et al., 
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2015). Advocating the usage of these evaluation tools in assessing HNCa patients 





Pre-radiation dental assessment of HNCa patients is an important matter for HNCa 
patients and health professionals. A variety of approaches toward managing patient 
dental needs is the main focus of discussion. Management of dental problems can be 
complicated by the complexity of the planned radiotherapy treatment, the patient’s 
dental condition and their motivation towards dental care. Socioeconomic factors, 
access issues and the influence of family and caregivers should also be considered. 
Barriers such as late referrals, lack of clinical guidelines and lack of knowledge among 
dental and medical professionals related to this issue can also hinder good quality of 




2.10 Research aims 
 
The aims of this study are: 
1. To investigate the knowledge and practice of dentists in Malaysia and New 
Zealand regarding pre-radiation dental assessment and management prior to 
radiotherapy treatment for patients with HNCa  
2. To determine the protocols or guidelines currently used by dentists in Malaysia 
and New Zealand for pre-radiation dental treatment 
3. To investigate the problems that are faced by dentists in Malaysia and New 
Zealand in providing dental treatment for HNCa patients that will be 
undergoing radiotherapy  
 
 
2.11 Research hypotheses 
 
1. The level of knowledge and practice of hospital dentists managing these 
patients will range from low to moderate 
2. Most of the hospital-based dentists will not be using specific protocols for pre-
radiation dental assessment for HNCa patients 






3.  MATERIALS AND METHODS 
 
3.1  Ethics approval, Maori consultation and Funding 
 
This research was a cross-national study related to topics surrounding pre-radiation 
dental assessment for HNCa patients. It compared differences between Malaysia and 
New Zealand. Ethical approval from both New Zealand and Malaysia was obtained 
before commencing this research. Ethical approval for the New Zealand arm of the 
study was obtained from the University of Otago Human Ethics Committee (H16/068), 
and the Ngāi Tahu research consultation committee was also consulted before 
commencing the research. Ethical approval from the Medical Research Ethics 
Committee at the National Institute of Health, Malaysia was obtained for the 
Malaysian arm of the project. This process ensured the project received all approvals 
required under Malaysian law. This included: (1) approval from the Economic Planning 
Unit at the Prime Minister's Department of the Malaysian Government, (2) 
institutional approval from the Oral Health Division at the Malaysian Ministry of 
Health, and (3) registration with the National Medical Research Registry of Malaysia. 
Funding for this research was provided by a Fuller Scholarship from the Faculty of 
Dentistry at the University of Otago. 
 
 
3.2  Participants 
 
According to the recent New Zealand Dental Council Workforce Analysis (2017), there 
were 20 hospital-based specialists and 78 general dentists that were employed by the 
District Health Boards (DHB) in 2015.  In Malaysia, the annual report by the Oral Health 
Division stated that there were 59 hospital-based specialists working under the 
Ministry of Health in 2014. There were 4021 general dentists/dental officers that were 
working in the public sector (dental public clinics and hospital-based dentistry) but the 
data for hospital-based dentists alone were not available. Dental paediatric specialists 
and oral medicine specialists were not included in this count for the purpose of this 
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study. Though Malaysia has a larger workforce the number of hospital-based dentists 
in Malaysia is still relatively small. Thus, the sample size of 50 participants was 
considered adequate for the purpose of this study. 
 
Hospital dentists working in Dental Departments during the period of questionnaire 
distribution were included in this study. They consisted of general dental practitioners 
(GDP), including house surgeons and registrars, oral and maxillofacial surgeons 
(OMFS), oral surgeons (OS), special needs dentist (SND) and other dental clinicians 
such as clinical practice manager, dental public health specialist, restorative specialist 
or prosthodontist who work with the hospital’s oral oncology patients at the date of 
survey.  Dental officers and first year dental officers (FYDO) in Malaysia are similar to 
GDP and house surgeon positions in New Zealand respectively. In both countries, those 
who were primarily based in private dental clinics and dentists who were working at 
the dental paediatric clinics or oral medicine clinics during the period of questionnaire 
distribution were also excluded. This is in relation to the low prevalence of HNCa 
incidence in children (thus excluding paediatric dental specialists) and the fact that this 
study relates to the specialist discipline of SND, not oral medicine, thus excluding oral 
medicine specialists.  
 
A list of Malaysian dental practitioners was acquired through the Dental Practitioner 
Information Management System (accessible online) of the Malaysian Dental Council. 
Potential participants were filtered by looking through the address provided and 
including those who listed a hospital as their location of practice. Further confirmation 
with the National Specialist Register, Malaysia Ministry of Health website was done to 
exclude registered paediatric dental specialists and oral medicine specialists. 
 
A list of New Zealand dental practitioners was obtained from the New Zealand Dental 
Council register (accessible online). Participants were selected by practice type; status 
as a specialist in oral and maxillofacial surgery, oral surgery, special needs dentistry, 
public health dentistry or general dental practice. Practitioner details were then 
matched by address to determine whether they were likely to be based in a hospital or 
private dental clinic.  
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The power calculation for sample size was estimated base on the number of hospital-
based specialists and dentist as previously discussed. Based on the confidence level of 
95% and confidence interval of 9.75, a sample size of 50 respondents was required. 
Simple random sampling was conducted using the Research Randomizer software and 




3.3  Questionnaire development 
 
No previous studies of pre-radiation dental assessment for HNCa patients have been 
conducted in Malaysia or New Zealand, but studies from Turkey, United States and 
United Kingdom have previously been published (Güneri et al., 2008; Patel et al., 2012; 
Alpöz et al., 2013; Dewan et al., 2014). In consideration of the findings of these 
previous studies, a 20-item self-administered questionnaire was developed for use in 
this study. The questionnaire had both quantitative and qualitative elements, and the 
questionnaire contents for both countries were similar except for the ethnicity section 
(Q2), reporting of current position (Q3) and referral from health professionals (Q10). 
The ethnicity section was classified according to Department of Statistics, Malaysia and 
Stats New Zealand Classification and Standards. For current position, house surgeon 
and general dentist in New Zealand were replaced with FYDO and dental officer in 
Malaysia respectively, which are similar in terms of definition and job scope. For 
referral from health professionals, general medical practitioner (GP) in New Zealand 
was replaced with medical officer in Malaysia. 
 
The main themes of the questionnaire were as listed: 
i. Socio-demographic data 
ii. Pre-radiation dental assessment 
iii. Multidisciplinary meetings 
iv. Clinical guidelines 
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v. Knowledge and practice regarding the dental management of patients that 
will be undergoing HNRT 
vi. Adequacy of training for management of HNCa patients 
vii. Barriers and suggestion to improve 
viii. Comment/suggestions 
 
Pre-testing of the questionnaire was conducted to evaluate the internal validity of the 
questionnaire. This was conducted by distributing the initial questionnaire to six 
people; two specialists (an oral surgeon and a special needs dentist), two general 
dentists and two experts in survey research both in Malaysia and New Zealand. The 
aim of this pre-test was to evaluate whether the questionnaire was appropriate in 
terms of structure, content and language that was being used. Feedback was provided 
and adjustments were made accordingly. The questionnaire did not need to be 
translated to Bahasa Melayu which is the official language in Malaysia as the 
respondents were specialist/dentists and it is known these types of professionals in 
Malaysia have a good level of proficiency in English 
 
 
3.4  Data Collection 
 
One hundred questionnaires (50 for each country) along with cover letters and 
information sheets (Appendix 8.5, 8.6 and 8.7) were posted out to the participants 
with a return stamped envelope. Those who had not responded within 8 weeks of the 
first wave were again invited to participate by a second mailing. Those who did not 
respond to the second mailing wave within a further 8 weeks were invited for a third 
time. In cases where a practitioner’s registered address was incorrect and an 
alternative correct address could not be identified, another randomly-selected 
practitioner was invited in their place.  
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3.5  Statistical analysis 
 
Data was analyzed separately for both countries using Statistical Package for the Social 
Sciences software (version 24.0; IBM Corp., Armonk NY). Descriptive analysis was used 
for categorical data. Categorical variables were described as frequencies and 
percentages. Continuous variables were described using mean and standard deviation. 
The Pearson's chi-square test was used to determine any statistical differences 
between two countries and association of variables. Fisher’s exact test was used to 
analyse small sample size. Independent sample T-test was done for continuous 
variables such as respondent’s working experience. Analysis of Variance (ANOVA) was 
then used to confirm the differences between the mean of working experience and 
working time in between these two countries. Simple linear regression analysis was 
used to observe the relationship between certain variables. 
 
The numerical data of working experience (in years) was converted to categorical data 
of level of working experience (low, moderate, highly experienced) based on the 
number of years they have been working as a dentist. The number of hospital-based 
working hours was divided into two groups, full time or part time. Full time and part 
time working hours were defined according to regulation in Malaysia and New 
Zealand. For Malaysia respondents, working more than 34 hours per week was 
considered as full time employment. As for New Zealand respondents, full-time 
employment was measured as working 30 hours or more per week. Some of the 
categorical data were recoded to simplify data analysis and results interpretation. 
Instead of four different categories, it was recoded into just two categories of 
responses. For example, ‘never and sometimes’ was recoded into one category and 




3.6  Analysis of the qualitative data 
 
A deductive approach was taken to analyse an open ended question in the 
questionnaire. The process of qualitative data analysis involved organizing the data, 
identify framework, sorting the data into framework, using the framework for data 
analysis and second order analysis. Recurrent and related themes were identified. 





4.  RESULTS 
 
100 questionnaires were posted out or emailed and the total number of respondents 
was 75; 40 from Malaysia and 35 from New Zealand. The response rate was 80% from 
Malaysia and 70% from New Zealand. The prevalence (%) of these results was counted 
within country unless stated otherwise in individual tables.  
 
 
4.1  Socio-demographic characteristics 
 
4.1.1 Characteristics of respondents 
 
Overall, there were similar proportions of respondents by gender. Ethnicity was 
classified differently for both countries. The main ethnicity groups in Malaysia were 
Malay, Chinese, Indian and indigenous people (Table 4). There were no respondents 
from the indigenous group.  
 
In New Zealand, ethnicity was categorized as European, Asian and others (Table 4). 
European, New Zealand European and other European respondents were classified 
under the European group. Asians consisted of Asian, Southeast Asian and Chinese. 
Due to the small number of respondents, Maori, Middle Eastern, African and others 
which were not specified were classified under ‘Others’  
 
There were significant differences in the respondents’ current positions (Table 4).  The 
majority of the respondents were ‘specialist/consultant’ for New Zealand and ‘dental 
officer’ for Malaysia. The specialist trainees that responded to the questionnaire 
consisted of Oral Surgery (OS) (4 people) and Special Needs Dentistry (2 people).  
 
The number of hospital-based working hours was divided into two groups, full time or 




Table 4 Characteristics of respondents by country 
 
 Malaysia  
N (%) 
New Zealand  
N (%) 
χ2 value (p value) 
Gender 
      Male 










      Malay 
      Chinese 
      Indian 
      European 
      Asian  





















      Consultant/specialist 
      Specialist trainee 
      Dental officer/general   
      dentist        
      FYDO/house surgeon 
      Others 
 
Full time hospital-based 
work 
      Yes 









































4.1.2 Respondent’s working experience 
  
The minimum working experience as a dentist for both Malaysian and New Zealand 
respondents was one year. The maximum was 23 years (Malaysia) and 46 years (New 
Zealand).  
 
The minimum time working in hospital-based dental care in both countries was 
recorded as zero years which was interpreted as less than one year. The maximum was 
23 (Malaysia) and 30 (New Zealand) (Table 5). 
 
Independent sample T-tests were carried out for all variables. The results were 
statistically significant, indicating that the group variances were unequal in the 
population. Welch’s t-test was done and was statistically significant. It was concluded 
that there was a difference between the mean work experience time working as a 
dentist and working in a hospital-based setup between the two countries. 
 
Table 5 Respondent's working experience by country 
 
 Malaysia New Zealand p value 
Years as a dentist    
      Mean 
      Median 









Years working in hospital- 
based 
   
      Mean 
      Median 









Hours per week working in 
hospital-based 
      Mean 
      Median 

















   *p<0.05 
38 
 
Working experience was divided into low, moderate and highly experienced based on 
the working hours provided. Half of the respondents from Malaysia were moderately 
experienced dentists (52.5%) while majority of the New Zealand respondents were 
highly experienced dentists (48.6%). Hospital-based dentistry work experience was 
mainly low in the Malaysian respondents and moderate for the New Zealanders. A 
significant difference of the working experience of the respondents was observed 
between these two countries (Table 6). It was concluded that the majority of the New 
Zealand respondents consisted of dentists with higher working experiences compared 
to the Malaysian respondents. 
 




New Zealand  
N (%) 
χ2 value (p value) 
Working experience as a dentist   16.753 (<0.001)* 
      Low  
      Moderate 














      Low 
      Moderate 






















4.2 Pre-radiation dental assessment details 
 
4.2.1 Number of HNCa patients seen (per year) and availability of fixed timeslots 
 
An independent-samples t-test was conducted to compare the mean number of HNCa 
patients seen by respondents in Malaysia and New Zealand. The respondents were 
asked to estimate the average number of HNCa patients that were seen by them prior 
to radiotherapy (per year). There was no significant difference in the number of 
patients seen in Malaysia (M=42, SD=98) and New Zealand (M=29, SD=44); t (55.6) = 
0.71, p = 0.479. Respondents were asked if fixed timeslots/scheduled appointment 
times/dedicated clinic appointments were available for pre-radiation dental 
assessment. Over two-third of respondents stated that they have a fixed timeslot to 
accommodate these patients for assessment (Table 7). 
 
Table 7 Availability of fixed timeslots for pre-radiation dental assessment by country 
 




χ2 value (p value) 





      Yes 
      No 











4.2.2 Radiographs taken during pre-radiation dental assessment 
 
Orthopantomographs (OPGs) were usually taken during the pre-radiation dental 
assessment (New Zealand respondents – 94.3% and Malaysian respondents - 67.5%). 
Intra-oral periapical radiographs (IOPAs) and posterior bitewings (PBWs) were 
sometimes taken. The differences in taking routine dental radiographs for HNCa 
patients between these two countries were statistically significant. Other radiographs 
taken were computerized tomography (CT) scan or cone beam computed tomography 
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scan (CBCT) (Table 8). But it was unclear in the analysis if these CT and/or CBCT were 
taken as part of determining cancer diagnosis and staging or requested separately by 
the dental team, specifically for dental assessment.  
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Table 8 Routine radiographs that was taken during pre-radiation dental assessment by country 
 























































































4.2.3 Characteristics of referrals 
 
Referrals for dental assessment in these two countries were done by two different 
groups of health practitioners. The majority of the referrals were from medical officers 
(MO) in Malaysia (75.0%) and radiation oncologists in New Zealand (88.6%) and there 
was a statistically significant difference between these routes of referral (Table 9). 
Most of the ‘other’ medical personnel that referred these patients were ORL specialists 
although there were also referrals from clinical nurse specialists (oncology), other 
hospital dental services, plastic surgeons and medical oncologists.  
 
Respondents were asked about the frequency and types of radiation information 
provided by the radiation oncologist at the time of referral.  Specific information 
required was type, location, dosimetry and commencement date of the radiation 
therapy. A statistically significant difference was observed in the responses with 41.9% 
of radiation oncologists in New Zealand ‘always’ providing the information compared 
to Malaysia (15.4%). Survey respondents in both countries highlighted that there were 




Table 9 Referral characteristics for pre-radiation dental assessment by country 
 




χ2 value (p value) 
Health personnel who made the 
referral a 
   
      Radiation oncologist 
      MO/GP 
      GDP 
















Radiation information provided 
by radiation oncologist 
(if applicable)b 
   
11.783 (0.019)* 
 
      Never 
      Sometimes 
      Often 













   a Multiple response question 
   
b 
N(%) by total of referral from radiation oncologist 
   *p< 0.05 
    MO= Medical Officer 
    GP= General Practitioner 






4.3  Multidisciplinary meetings  
 
More than half of the respondents in Malaysia and New Zealand stated that MDMs 
took place at their centres (Table 10). The main health practitioners that were involved 
in MDMs were radiation oncologists, dentists, OS/OMFS and ORL surgeons. There was 
a statistically significant difference between the composition of the MDMs with 
variation in the inclusion of associates such as dieticians, audiologists/speech 
therapists, clinical specialist nurses, head and neck cancer co-ordinators and others. In 
Malaysia, the main  other health practitioners involved were plastic surgeons, whilst in 
New Zealand other health practitioners comprised pathologists, radiologists, plastic 
surgeons, oral medicine specialists, rehabilitation specialists, social workers, medical 
oncologists, prosthodontists and dental technicians. 
 
Table 10 Differences in multidisciplinary meeting arrangements by country 
 
 Malaysia  
N (%) 
New Zealand  
N (%) 
χ2 value (p value) 
Held at centre 
      Yes 
      No 















involved in MDM 
      Radiation oncologist 
      ORL 
      OS/OMFS 
      Dentist 
      Dietician 
      Audiologist/speech 
      therapist 
      Clinical specialist nurse 
      Head and neck cancer  
      co-ordinator 











































   *p < 0.05 
    ORL= Otorhinolaryngology 
    OS= Oral Surgeon 




Practitioners who worked in major cities were more likely to participate in MDMs than 
practitioners in small centres, and the observed difference was statistically significant. 
50% of the New Zealand practitioners who participated in MDMs were significantly 
more likely to report that they followed a published clinical guideline for the dental 
management of HNCa patients who would be undergoing radiotherapy treatment. 
However, only 4.7% of the Malaysia practitioners who were involved with the MDM 
would practice the same thing (Table 11). 
 
Table 11 Associations between MDM, location and usage of clinical guideline by 
country   
 
 Malaysia  
N (%) 
New Zealand  
N (%) 
χ2 value (p value) 
MDM held in major cities 18 (85.7) 13 (72.2) 24.930 (<0.001)* 
Participation in MDM and usage 
of clinical guideline by 
respondents 
1 (4.76) 9 (50.0) 7.835 (0.020)* 
   *p <0.05 









4.4  Clinical guidelines for pre-radiation dental assessment 
 
4.4.1 Usage of clinical guidelines 
 
The majority of Malaysian respondents did not use formal clinical guidelines for dental 
assessment of HNCa patients prior to radiotherapy treatment (Table 12). Many were 
unaware such guidelines existed. Only one person mentioned that he/she used a 
guideline, but the actual guideline was not specified. As for New Zealand respondents, 
almost half of them mentioned that they used clinical guideline(s). A significant 
difference was observed between these two countries.  
 
Table 12 Usage of clinical guidelines for pre-radiation dental assessment by country 
 
 Malaysia  
N (%) 
New Zealand  
N (%) 
χ2 value (p value) 
Yes 1 (2.5) 17 (48.6) 21.751 (<0.001)* 
No, I am aware of a guideline but 
do not follow it 
5 (12.5) 2 (5.7)  
No, I am not aware of any such 
guidelines 




New Zealand respondents used a mixture of resources as guidelines such as national 
guidelines, journal articles, hospital protocols and local guidelines (Table 13). The 
guidelines used by the New Zealand respondents were as listed (in no particular 
order): 
 
i. The Royal College of Surgeons of England / The British Society for Disability and 
Oral Health (2012). Oral management of oncology patient requiring 
radiotherapy, chemotherapy and bone marrow transplant: Clinical guideline. 
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ii. National Head and Neck Cancer Tumour Standards Working Group. 2013. 
Standards of Service Provision for Head and Neck Cancer Patients in New 
Zealand - Provisional.  
iii. Studer G, Glanzmann C, Studer SO, Grätz KW, Bredell M, Locher M (2011). Risk-
adapted dental care prior to intensity-modulated radiotherapy (IMRT). Schweiz. 
Monatsschr. Zhanmed; 121: 216-229. 
iv. Ben-David MA, Diamante M, Radawski JD, Vineberg KA, Stroup C, Murdoch-
Kinch CA, et al (2007). Lack of osteoradionecrosis of the mandible after 
intensity-modulated radiotherapy for head and neck cancer: Likely 
contributions of both dental care and improved dose distribution. Int. J. Radiat. 
Oncol. Biol. Phys: 68: 396-402 
v. Buglione M, Cavagnini R, Di Rosario F, Sottocornola L, Maddalo M, Vassalli L, et 
al (2016). Oral toxicity management in head and neck cancer patients treated 
with chemotherapy and radiation: Dental pathologies and osteoradionecrosis 
(Part 1) literature review and consensus statement. Crit. Rev. Oncol. Hematol; 
97: 131-142 
vi. Walsh LJ (2010). Clinical assessment and management of the oral environment 
in the oncology patient. Aust. Dent J; 55: 66-77 
vii. Referred paper/journal articles/consensus statement 
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More than 7 to 
10 days before 
cancer 
treatment 















Information not available 
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4.4.2 Association between respondent's characteristics and usage of clinical 
guidelines 
 
Consultants/specialists used guidelines more often compared to other dentists 
(61.1%). GDP/dental officer usually were not aware of any guidelines available in 
managing these patients compared to other groups (44.0%). Among the 
consultant/specialist group, SND specialists usually used guidelines for managing this 
group of patients (54.5%) followed by Dental Public Health or Master of Community 
Dentistry (DPH/MComDent) graduates. Majority of the OS/OMFS were not aware of 
any available guidelines pertaining to this matter (75.0%).  The majority of the dentists 
with limited experience were not aware of any available guidelines (56.0%). A 
statistically significant association was observed for specialization, working experience 
as a dentist and hospital-based working experience (Table 14). 
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Table 14 Association between respondent's characteristics and usage of clinical 
guidelines 
 
 Do you follow a clinical guideline for pre-radiation dental assessment? 
 Yes No, I am aware of 
a guideline but do 
not follow it 
No, I am not 
aware of any 
such guidelines 
 p value 
 N (%) N (%) N (%)  
Current position  
   
0.058 
   Consultant/specialist 11 (61.1) 3 (42.9) 12 (24.0)  
   Specialist trainee 1 (5.6) 2 (28.6) 3 (6.0)  
   GDP/ dental officer 5 (27.8) 2 (28.6) 22 (44.0)  
   House surgeon/ FYDO 1 (5.6) 0 (0.0) 12 (24.0)  
   Other 0 (0.0) 0 (0.0) 1 (2.0)  
Specialization     0.001* 
   OS/OMFS 2 (18.2) 3 (100) 9 (75.0)  
   SND 6 (54.5) 0 (0.0) 2 (16.7)  
   DPH/MComDent 3 (27.3) 0 (0.0) 1 (8.3)  
Working experience (as 
a dentist)  
   0.020* 
   Low  1 (5.6) 2 (28.6) 23  (46.0)  
   Moderate 8 (44.4) 3 (42.9) 18 (36.0)  
   High 9 (50.0) 2 (28.6) 9 (18.0)  
Hospital-based working 
experience  
   0.007* 
   Low 2 (11.1) 2 (28.6) 28 (56.0)  
   Moderate 14 (77.8) 3 (42.9) 18 (36.0)  
   High 2 (11.1) 2 (28.6) 4 (8.0)  
   *p < 0.05 
    N (%) by columns 




The MDM team was classified into groups depending on the number of specialities of 
other health practitioners involved. 46.2% had one to four specialities involved in their 
MDM while 53.8% had the involvement of five to nine specialities. 41.0% of the MDM 
with this large group of people were held in major cities. It is noted that 77.8% of the 
respondents who were not involved in MDM, did not follow any guideline and were 
not aware of such guidelines. For groups that had five to nine health practitioners 
involved in their MDM, only 38.1% of the dentists used guidelines while 52.4% were 
not aware of any available guidelines. There were statistically significant associations in 
the number of specialities involved in MDM with the availability of MDM held in their 
respective centres and also MDM that was held in major cities compared to the small 
cities (Table 15).  
 
Table 15 Associations between MDM meetings and guideline usage with the MDM 
team size  
 Number of specialities involved in MDM 
 









χ2 value  
(p value) 
 










Practicing in major city a 
    
24.793(<0.001)* 
      Yes 0 (0.0) 15(38.5) 16 (41.0)  
      No 0 (0.0) 3 (7.7) 5 (12.8)  
 
Following a guideline b 
    
14.346 (0.006)* 
      Yes 8 (22.2) 2 (11.1) 8 (38.1) 
 
      No, I am aware of a   
      guideline but do not   
      follow it 
 
0 (0.0) 5 (27.8) 2 (9.5) 
 
      No, I am not aware   of  
      any such guidelines                           28 (77.8) 11 (61.1) 11 (52.4) 
 
   *p < 0.05 
    
a
 N (%) by total MDM held 
    
b
 N (%) by columns 
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4.5  Knowledge and practice regarding the dental management of HNCa 
patients that will be undergoing HNRT  
 
4.5.1 Commencement of dental treatment 
 
Almost all of the respondents would commence dental treatment at least 2 weeks before 
radiotherapy started. Only a small number of respondents would do it after radiotherapy 
finished and no responses were noted for other statements (Table 16).  
 
Table 16 Commencement of dental treatment by country 
 
 Malaysia  
N (%) 
New Zealand  
N (%) 
χ2 value  
(p value) 
 
At least 2 weeks before    
radiotherapy 
 
Less than 2 weeks before 
radiotherapy treatment 
 
During the radiation therapy 
period 
 
After radiotherapy  treatment 
 








































4.5.2 Oral complications related to HNRT 
 
Complications of radiotherapy that were ‘often/always’ seen were mucositis and 
xerostomia. The majority of respondents mentioned that they ‘never/sometimes’ 
encountered ORN, trismus and candidiasis as complications of radiotherapy treatment. 
Other complications that had been observed include altered taste (dysgeusia), dysphagia 
and failure of existing heavily restored teeth or implants (Table 17). 
 
Table 17 Frequency of HNRT-related oral complications observed by country  
 
 Never/Sometimes Often/Always χ2 value  
(p value) 
Malaysia  








































































































4.5.3 Management or advice provided during pre-radiation dental assessment 
 
The majority of respondents in both countries would ‘often/always’ provide advice 
regarding oral hygiene practice (OHP), diet, lifestyle changes such as smoking cessation 
and reduced alcohol intake, side effects of HNRT, the importance of regular dental recalls 
and regular fluoride use.  Almost all of the respondents from both countries 
‘never/sometimes’ fabricated fluoride trays or mucosal guards/radiation stents (Table 
18). 
 
Other types of advice provided by the Malaysian respondents were the recommendation 
to increase water consumption due to dry mouth, use a super soft toothbrush during 
periods of mucositis and information about types of dental products to use or avoid 
during and post HNRT. The New Zealand respondents gave additional advice that included 
information on ways to manage xerostomia, dry mouth products (oral lubricants and 
saliva substitutes) and chlorhexidine mouthwash usage when required.  Specific advice 
related to treatment planning was also described where appropriate, for instance 
antibiotic cover for invasive dental treatment, steroid cover and medication changes to 







Table 18 Management or advice provided by country 
 
 Never/Sometimes Often/Always χ2 value  
(p value) 
Malaysia  





















Diet analysis and 
advice 
15 (37.5) 7 (20.0) 25 (62.5) 28 (80.0) 2.758 (0.129) 
Advice on lifestyle  7 (17.5) 5 (14.3) 33 (82.5) 30 (85.7) 0.143 (0.762) 















































































Table 19 refers to the management of xerostomia and caries/radiation caries to prevent 
complications. Respondents that observed caries/radiation caries among their HNCa 
patients previously, were more likely to provide fluoride trays for at-home use for their 
future patients.   However, there was no relationship noted between the frequency of 
complications observed (xerostomia and caries/radiation caries) with others preventative 
management provided by the respondents  
 
Table 19 Regression model for complications (caries/radiation caries, xerostomia) and 
preventative management 
 
 Xerostomia Caries/radiation caries 
 Coefficients p value Coefficients p value 
Evaluation and 
reinforcement of OHP 
0.350 0.190 0.446 0.109 
Diet analysis and advice 0.070 0.555 0.048 0.696 
Importance of regular 
dental recall 
0.137 0.586 0.034 0.896 
Regular fluoride use 0.282 0.115 0.017 0.928 
Fabrication of fluoride trays 0.191 0.059 0.228   0.030* 





Respondents who used any clinical guideline in managing these patients were more likely 
to evaluate and reinforced patient’s oral hygiene practice. Apart from that, there was no 
relationship between the usage of guidelines for managing the dental needs of these 
patients and the types of advice or management provided by the dentists. The 
management provided was similar whether the respondents used any guidelines or not 
(Table 20).    
 
Table 20 Regression model for usage of clinical guideline and preventative management 
     Usage of clinical guidelines 
 Coefficients p value 
Evaluation and reinforcement of OHP 0.409   0.010* 
Diet analysis and advice 0.006 0.937 
Advice on lifestyle changes 0.012 0.882 
Side effects of radiation therapy 0.165 0.170 
Importance of regular dental recall 0.113 0.493 
Regular fluoride use 0.183 0.074 
Fabrication of fluoride trays 0.043 0.496 
Fabrication of mucosal guards 0.041 0.641 






4.6 Perceived adequacy of training 
 
There were contradictory responses regarding the perceived adequacy of 
undergraduate training between the two countries and there was a statistically 
significant difference between them. More than half of the Malaysian respondents 
(65.0%) mentioned that they had adequate undergraduate training in this field while 
three-quarters of the New Zealand respondents (82.9%) felt they had inadequate 
undergraduate training. The majority of the consultants/specialists and specialist 
trainees responded that they had adequate postgraduate training regarding the 
management of oral health in patients receiving head and neck radiotherapy.  
 
Two-thirds of the respondents from both countries stated that they had not attended 
any radiotherapy-related courses in the past three years. Most of them mentioned 
that they would like to attend such courses or have further training in relation to this 





Table 21 Perceived adequacy of training and training needs by country 
   *p <0.001 
    
a
N(%) within consultant/specialist and specialist trainee 
 
 
Fourteen respondents from Malaysia (35%) and 29 from New Zealand (82.9%) thought 
their undergraduate training in management of radiotherapy-related oral problems 
was inadequate.  
 
For postgraduate training, there was one Malaysian respondent and six New Zealand 
respondents. More than half of the highly experienced dentists in New Zealand felt 
that they had inadequate undergraduate and postgraduate training in this field. There 
was a similar distribution related to perceived inadequacy of training in dentists with 
low and moderate levels of work experience between these two countries. A 
statistically significant difference was observed for inadequate undergraduate training 
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training (if applicable)a 
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Have attended related 
course in last 3 years 
      Yes 














Need to attend courses 
      Yes 














Table 22 Association between perceived adequacies of training with level of work experience by country 
 
 Level of work experience 
 
 Low  Moderate  High (%)  
 Malaysia  











 p value 
 
Inadequate undergraduate 


















training (if applicable) 
0 (0.0) 
 
1 (16.7) 1 (100) 
 
1 (14.3) 0 (0.00) 
 
4 (66.6) 0.413 
   *p <0.05 
     Analysed with Fisher’s exact test  
     N (%) within inadequacy of undergraduate or postgraduate training 






4.7  Barriers faced in managing HNCa patients prior to radiotherapy 
treatment and suggestions for improvement 
 
The majority of respondents from both countries noted that the main barrier to 
manage the dental needs of patients who will be receiving radiotherapy was lack of 
clinician’s time. The problems faced by respondents in both countries were similar 
except for lack of public health funding for dental care post-radiotherapy which was 
significantly more of a problem in New Zealand (Table 23). Other problems mentioned 
include lack of awareness from the medical team, lack of patient awareness, late 
referrals, low quality of referrals and lack of communication with other specialties. This 
will be discussed further in section 4.8.6. 
 
More than half of the respondents recommended further training as one of the main 
suggestions for improvement. They also recommended having some time released 
from other duties to enhance the provision of care provided to this particular group of 
special needs patients. Other suggestions include educating the medical team in 
relation to early and quality referrals, improved patient education regarding the 
importance of dental care post-radiotherapy and better communication between 
health professionals. 
 




 N (%) 
χ2 value (p value) 
Problems faced 







      Lack of funding 
      Lack of appropriate facilities 











Suggestions for improvement 
   
      Further training 
      Financial support 
      Time being released from  
      other duties 















  0.335 (0.579) 
   *p <0.05 
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51.1% of dentists with little work experience suggested further training as their main 
recommendation to enhance the delivery of care and this was statistically significant. 
The moderately and highly experienced dentists preferred to have more time or being 
released from other duties to improve patient’s care (Table 24). 
 
Table 24 Suggestions to enhance care according to working experience as a dentist 
 
 Working experience (as a dentist) 
 Low Moderate High p value 
 N (%) N (%) N (%)  
Further training 23 (51.1) 15 (33.3) 7 (15.6)   0.001* 
Financial support 3 (20.0) 8 (53.3) 4 (26.7) 0.332 
Time/being released from 
other duties 
10 (33.3) 9 (30.0) 11 (36.7) 0.238 
Othersa 2 (13.3) 6 (40.0) 7 (46.7) 0.071 
   *p <0.05 
   
a
Refer section 4.8 
   N (%) by rows 











4.8  Ways to improve the delivery of dental care to head and neck 
cancer patients that will be undergoing radiotherapy treatment. 
 
This was an open-ended question in the survey that added a qualitative element to the 
questionnaire. It invited respondents to offer comments and suggestions with regards 
to the research itself or to the improvement in provision of dental care for 
radiotherapy patients. The analysis of this question resulted in the emergence of 
multiple issues which were further classified into health professional factors, patient 
factors, referral issues, management issues, guideline issues and general issues. 
 
4.8.1 Health professional issues 
 
4.8.1.1 Educating the health professionals  
 
Respondents mentioned that it is crucial to educate the medical team regarding the 
importance of dental assessment as part of patients’ overall care. The target group 
should be radiation oncologists and ORL specialists. Involvement of other health 
professionals is encouraged. This will also affect the quality of referrals made by the 
medical team. For example, one participant mentioned that “all teams involved in 
managing HNCa patients should be exposed in managing cancer patients holistically”. 
 
Dentists should be well-trained to manage the dental issues that might rise post-
radiotherapy. In order to achieve this, good clinical acumen is needed to predict the 
dental outcomes during pre-radiation dental assessment. The need to “raise 
awareness among the dentist/medical team regarding the importance of pre 
radiotherapy and post radiotherapy follow up and preventive management” was 
noted. Regular dental recalls after radiotherapy were often forgotten. Regular recalls 
will help patients with any dental issues, manage dental complications related to 





Suggestions such as incorporating this topic into the undergraduate dental curriculum 
and into relevant postgraduate speciality dental curricula were also highlighted. 
Respondents noted that there was inadequate undergraduate training to prepare 
dentists to manage the dental needs of HNCa patients. For example, one of the 
respondents mentioned that “further undergraduate training is needed to improve the 
management of these patients”. However, theory should coincide with practical care. 
Hospital-based dental clinics in small cities might be lacking in the number of HNCa 
patients seen when compared to the major centres. As one respondent stated, 
“provincial hospitals may not provide adequate patient for clinical experience in 
managing these patients”. An insight from this particular respondent summarized this 
particular point: “inadequate undergraduate training maybe due to majority of 
graduates will be working in private sector and will not manage these patients”. The 
rise of HNCa prevalence worldwide indicates that there will be an increase in number 
of HNCa patients needing pre-radiation dental assessment and treatments. 
 
 
4.8.1.2 Improve communication between health professionals 
 
There were instances where patients had to be seen by a local hospital-based dentist 
prior to their radiotherapy treatment or return to their care after completion of 
radiotherapy. Good communication should be established between the dentist in the 
main cancer centre and the local dentist. Enhancement of communication between 
dentists and radiation oncologists, ORL surgeons and other medical professionals is 
also important. This will lead to crucial information sharing thus improving patient’s 
care. “Improve communications between GDP and hospital dentist/specialist” will 
established good post-radiotherapy care especially after patient is being discharged 






4.8.2 Patient factors 
 
Respondents noted that sometimes the delivery of care was complicated by patient 
factors. Lack of patient awareness, lack of self-dental care and refusal of care can be 
challenging.  For example, one respondent mentioned that “patient education is 
important. It will be a long term commitment to oral hygiene care post radiotherapy 
and dental recall. Oral hygiene is easily forgotten among the chaos, but long term 
complications can be debilitating”. 
 
Patient education and awareness is important especially the side effects of 
radiotherapy on dental environment and how they can minimize these complications. 
One of the respondents recommended there be “enhanced patient awareness such as 
the importance of dental treatment before radiotherapy, follow instructions and attend 
dental appointments”. Information should be given in a simple manner and proper way 
because it can be “quite overwhelming for patients, need tactful delivery of 




4.8.3 Referral issues 
 
The need for timely referrals and good quality referrals was a key issue identified in 
this research project. Respondents emphasized the need to “raise awareness among 
radiation oncologists and medical team to refer patients” to the dentists before HNRT. 
The majority of the respondents mentioned that they could not deliver optimal dental 
care due to late referrals. There was not enough time between receipt of the referral 
and commencement of radiotherapy treatment. One respondent mentioned that 
there was “limited time to stabilize patients prior to radiotherapy (higher risk for post 
op complications)”. This was mainly related to the healing period if teeth were 
indicated for extractions. The options available were either to delay radiotherapy 
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treatment or treat the patient after radiotherapy finished. Both can impose 
debilitating consequences on the patients. 
 
Good quality referrals were also crucial. The majority of the respondents noted that 
important information was often not included. Radiation information such as 
commencement date, type, location and dosage was not readily available. One 
respondent suggested to “have a standardised info from referring ENT/oncologist 
regarding the radiotherapy dosimetry”. This information would determine the types of 
dental treatments that will be provided. 
 
 
4.8.4 Management issues 
 
Head and neck cancer patients should be managed holistically. MDM discussions for 
larger centres or maybe combined clinics for small centres will enhance the delivery of 
care. For example, one of the respondents mentioned that “if radiotherapy is 
indicated, teeth can be removed during tumour surgery which can reduce waiting time 
for radiotherapy”. There were concerns as to which dentist/specialist was supposed to 
see these patients and continue with the dental care post-radiotherapy. Most patients 
would be seen by hospital-based dentists or OMS/OMFS. There were 
recommendations that HNCa patients should be seen by the Special Needs Dentist if 
possible. For example, one respondent noted that “all HNCa patients should be 
referred to a Special Needs Dentist. SND specialist should be included in MDT 
clinic/Meeting”. Consistency and continuation of care is the aim when providing 
treatment for HNRT patients. One respondent requested “better access for electronic 







4.8.5 Clinical guideline issues 
 
Absence of clinical guidelines can affect the planning of dental care. Most of the 
treatments provided were based on experience, rather than evidence-based. A 
national guideline for one’s particular country would be beneficial. One of the 
respondents recommended that “there should be a Clinical Practice Guideline from 
Ministry of Health, then dissemination of guideline and knowledge to all dentists, 
especially hospital-based dentists”. Respondents in certain facilities commented that 
they needed “more clear guideline/policies at Dental School” 
 
 
4.8.6 General issues 
 
Some unclassified comments or suggestions were placed under the general issues 
heading. Lack of funding has effects on human resources and the ability to provide 
comprehensive care for these patients. For example, one of the respondents 
mentioned “lack of funding- one specialist maxillofacial prosthodontist for one 
day/week is not sufficient for complex obturator cases”. Another respondent stated 
that “implants are not funded for rehab”.  
 
As for the research itself, one of the respondents commented that this is “beneficial 
research in improving dental care among HNCa patients”. Future research related to 
this topic was welcomed. One of the respondents suggested doing a “comparison 
study of knowledge and awareness between dentist and medical personnel” of pre-
radiation dental assessment. Another respondent mentioned that they “did audit 
outcomes of ORN and the incidence was low. Interested to use PENTOCLO 
(pentoxifylline-tocopherol-clodronate) protocol as an alternative to HBO (hyperbaric 





Finally, a positive comment from this respondent highlighted that not all is bad for 
HNRT patients that need dental care: “doing well in our centre. Good referral 
pathways & communication. Dedicated time slots and good follow up”. 
 
 
4.9 Summary  
 
Results showed that the socio-demographic features of the respondents were different 
between Malaysia and New Zealand in terms of their current position and work 
experience. Most of the pre-radiation dental assessment referrals came from radiation 
oncologists but radiation information was rarely provided upon referral. 
Multidisciplinary meetings were usually held at hospitals located in major cities. There 
was a difference between these two countries regarding involvement of health 
practitioners in MDM. New Zealand had more diverse groups of health professionals 
compared to Malaysia. Almost half of the New Zealand respondents used some form 
of clinical guidelines for pre-radiation dental assessment while most of the Malaysian 
respondents noted that they were not aware of any such guidelines. But there were a 
variety of guidelines used. 
The most common radiotherapy-related oral complications encountered by the 
respondents were mucositis and xerostomia. Trismus and ORN were rarely seen. The 
most common management or advice provided was evaluation and reinforcement of 
OHP, emphasising the importance of regular recall and regular fluoride use. Fluoride 
trays and mucosal guards/radiation stent were rarely fabricated. These results were 
similar in both countries. 
The majority of the New Zealand respondents mentioned that they had inadequate 
undergraduate training in relation to pre-radiation dental assessment of HNCa 
patients. But this was more prominent among the dentists/specialists that had 
graduated more than 15 years ago. Respondents in both countries were keen to attend 
any related courses pertaining to this topic. 
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The respondents mentioned that the barriers that they faced in providing dental care 
for these patients included late referral which led to inadequate time to provide 
optimum dental care, poor quality of referral, lack of clinician’s knowledge in managing 
these patients and unavailability of guidelines and protocols. Patient factors such as 







5.1  Overview 
 
The aim of this research was to analyse the current practice of hospital-based dentists 
in managing the dental needs of HNCa patients that will be undergoing radiotherapy 
treatment. It was a comparison study between Malaysia and New Zealand. These two 
countries were chosen because of the variation in incidence and aetiological factors for 
HNCa. It was also to simplify the survey process since we have contacts in both 
countries.  
 
The analysis of the data identified areas which required more in-depth discussion and 
research in relation to the pre-radiotherapy dental management of HNCa patients. The 
main area of concern was the dentists’ knowledge and practices regarding oral 
complications of HNRT and suitable treatments of dental diseases for this group of 
patients. Challenges were highlighted and suggestions were offered in order to 
enhance patients’ care. The discussion section will highlight methodological issues, 
findings of our research, the significance of these results and future research. 
 
 
5.2 Methodological issues 
 
5.2.1 Study design 
 
This research was a cross-national study related to topics surrounding pre-radiation 
dental assessment for HNCa patients. We incorporated a qualitative element into this 
questionnaire to capture respondents’ thoughts on issues related to managing the 
dental needs of HNRT patients and the research itself. There might be topics that we 
never thought about, and through open-ended questions, we hoped additional ideas 




5.2.2 Response rate 
 
The response rate by country was 80% for Malaysia and 70% for New Zealand. This 
number is comparable to the wider sample population of hospital specialists and 
dentists and also other studies in the field. Thus, it provides a representative sample 
for this study. The three-wave mailing/emailing system helped to increase the 
response rate. No monetary incentives were offered. This study highlighted workforce 
differences in each country, reflected by responses in the category 'current position'. 
The majority of the respondents were ‘specialist/consultant’ in New Zealand and 
‘dental officer’ in Malaysia. This coincided with the level of work experience of 
respondents. Since this questionnaire reflected on knowledge and practice, there is 
the possibility of significant differences between the answers for these two countries. 
 
We have to acknowledge the differences in terminology and pathways of care for 
Malaysia and New Zealand during questionnaire development. Fortunately, the 
majority of the questionnaire’s content was similar except for certain terminology such 
as the professional position of dental and medical practitioners. This topic will be 
discussed further under the next heading.  
  
 
5.3 Defining terms and classifications in results 
 
The variable for working hours at hospital-based settings were categorically classified 
into full time or part time, based on the answers provided. In order to do this, we 
followed the definition of full time working hours in Malaysia and in New Zealand.  
According to Section 2(1) and 60A, Malaysia Employment Act 1955 (amendment 2012), 
fulltime employment working hours are 8 hours per day or 48 hours per week. A part 
time employee has working hours between 30% up to 70% of fulltime working hours. 
In short, part time means working less than 34 hours less per week. Thus, for this 
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study, working for more than 34 hours per week was considered to be full time 
employment for Malaysian respondents. In New Zealand, employment legislation does 
not define what full-time or part-time work hours is, but full-time work is often 
considered to be around 35 to 40 hours a week (Employment New Zealand, 2017). For 
statistical purposes, Statistics New Zealand defines full-time as working 30 hours or 
more per week. For the purpose of this study, we considered working 30 hours or 
more per week was full-time employment in New Zealand. The level of working 
experience was categorically classified based on the researcher’s own classification to 
simplify data analysis and results interpretation. It depended on the number of 
working years. It was categorised into low (1 to 5 years), moderate (6-15 years) and 
highly-experienced (16 years and above). 
 
Some answers had different terminology between countries but were similar in terms 
of definition and job scope. This applied to the answers for question 3 (current 
position) and question 10 (referrals from health practitioners). For instance, first year 
house surgeon and general dentist in New Zealand were replaced with FYDO and 
dental officer in Malaysia respectively for Question 3. As for Question 10, GP in New 
Zealand was substituted with medical officer in Malaysia. 
 
 
5.4 Overview of the healthcare system in Malaysia and New Zealand 
 
An overview of healthcare system in Malaysia and New Zealand will provide a better 
understanding of the background to this study. The policies of the healthcare systems 
are likely to affect the dental management and outcomes for HNCa patients. There are 
two types of medical healthcare systems in Malaysia and New Zealand, public and 
private health services. The path of referral is generally the same; from primary 
healthcare to secondary or tertiary hospitals. Dental management for HNCa patients is 
usually provided by hospital-based dentists in both countries. The role of GDP in 
primary settings for this group of patients is still debatable due to the complexity of 
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the treatment needs such as determining the extraction needs in relation to the 
radiotherapy dosimetry and ORN risk and obturators fabrication if needed. Teeth can 
also be extracted during tumour surgery under general anaesthesia to reduce waiting 
time for radiotherapy treatment and consequently minimize apprehension towards 
dental treatments.  
 
 
5.4.1 Healthcare system in Malaysia 
 
Malaysia practices the universal health coverage. Healthcare is heavily subsidized for 
Malaysian citizens and permanent residents. As a result, healthcare can either be 
inexpensive or free of charge. Majority of Malaysians rely heavily on the public 
healthcare system. Primary healthcare is largely provided by public health care clinics.  
Private medical services, either hospital or general practices mainly play a supporting 
role for the public healthcare system. Public healthcare is widely available throughout 
the country. Currently, there are 408 public hospitals and 934 public health clinics in 
Malaysia serving a population of around 31 million people (Malaysian Ministry of 
Health, 2017). The dental healthcare system is quite similar in terms of the general 
scope and funding. Most dental healthcare in Malaysia is provided by dental public 
clinics all over Malaysia. Hospital-based dentistry is only available in certain number of 
hospitals (around 10%). Private dental services act as a support for public dental 
healthcare.  
 
The Defence and Higher Education Ministries also run their own hospitals. They 
provide both medical and dental care at their vicinity. Currently, there are three 
military hospitals and four university hospitals in Malaysia. The military hospitals 
provide healthcare to the army and their immediate families while the university 






5.4.2 Healthcare system in New Zealand 
 
In New Zealand, primary healthcare is usually in a private setting while hospital care 
can either be privately or publicly funded in contrast with Malaysia. The District Health 
Boards (DHB) which are entities under the Ministry of Health, have service agreements 
with DHB provider arms and also with the private and Non-government Organization 
providers. Primary health care relates to the professional health care provided in the 
community. The health personnel involved are GP, practice nurse, pharmacist or other 
health professional working within a general practice. It is recommended that 
everyone in New Zealand enrols with a GP. As of April 2014, there were 32 primary 
health organisations and 1029 GPs in New Zealand (New Zealand Ministry of Health, 
2017).  
 
There are 20 DHBs in New Zealand with 40 public hospitals across the whole country. 
With minor exceptions, hospital treatment is free for those eligible for health care 
services. According to the New Zealand Ministry of Health, government funding in 
relation to health and disability services means that eligible people may receive free 
inpatient and outpatient public hospital services, subsidies on prescription items and a 
range of support services for people with disabilities in the community.  
 
Dental services are not part of the free public health system. It is only free for children 
and adolescents under 18 years old. Dental care for adults is provided by oral health 
care practitioners in private practices. There is a limited range of dental services 
funded for some adults. This include adults with special medical needs or disabilities 
that make them unable to access normal dental services, or who require dental 
treatment as part of other treatment (such as for HNCa). They can receive free hospital 
dental services. People on low incomes who have a Community Services Card may be 
able to get funded emergency dental care, such as pain relief or extractions. These 
services are provided at hospital-based dental settings or by dentists contracted by the 




The Faculty of Dentistry, University of Otago is considered to be a separate entity with 
regards to this arrangement. It is under the rules and regulations of the University of 
Otago, but it also works together with the Southern DHB, using Dunedin Public 
Hospital. The management of HNCa patients in Otago are mainly under the jurisdiction 
of SDHB. They partner with the Faculty of Dentistry for management of the dental 
aspects for these patients. Other DHBs have a hospital-based dental setting which 
accepts referrals from the MDM setting, oncology department and ORL department to 
manage the dental needs of HNCa patients. 
 
The difference in the dental management of HNRT patients between Malaysia and 
New Zealand is prominent after patients are discharged from the hospital dental 
service. Is it widely known that HNRT patients need regular dental recalls because they 
are considered as a high risk group. In Malaysia, patients have the option to continue 
follow up with the public or private dental clinic. Whereas in New Zealand, a patient 
has to see a GDP for routine check-ups upon discharge. The cost of post-radiotherapy 






5.5.1 Pre-radiation dental assessment 
 
The aim of pre-radiation dental assessment is to reduce oral complications related to 
HNRT. In the United Kingdom, up to a third of the HNCa patients in the acute care 
trusts are at risk of suboptimal dental health before starting cancer treatment  
(Lawrence et al., 2013).  It is recommended that a proforma for assessing HNCa 
patients should include “dental assessment before radiotherapy” (Lawrence et al., 
2013). This might increase referrals to the dentist consequently reducing dental 




Pre-radiation dental assessment relies heavily on referrals from the medical personnel, 
mainly radiation oncologists as confirmed by the current study. This is really helpful 
because radiation information can be provided upon referral for dental assessment. 
However, our findings noted that only a small number of referrals ‘always’ provided 
the information; 15.4% (Malaysia) and 41.9% (New Zealand). There were quite a 
significant number of radiation oncologists who never provided any radiation 
information during referrals. 
 
The majority of the respondents mentioned that they could not deliver the optimum 
dental care due to late referrals. There was not enough time between referral receipt 
and commencement of radiotherapy treatment. Good quality referrals were also 
crucial. The majority of the respondents noted that important information such as 
commencement date of radiotherapy and radiation dosimetry usually was not 
included. Without this information, it was difficult to plan dental treatment and 
delivery of care was delayed. Efficient referrals can be improved by adopting the risk-
adapted dental care (RaDC) (Studer et al., 2011) and Dentalmaps (Thariat et al., 2012). 
Both can provide detailed dosimetry information which is very helpful in managing the 
dental needs of HNCa patients. 
 
Previous studies looked into the types of radiographs that should be taken during the 
dental assessment. An OPG is considered to be the optimal baseline radiograph for this 
group of patients. It is a rapid, convenient and simple method to demonstrate a 
patient’s general dental condition. Periodontal disease, impacted wisdom teeth, 
endodontically treated teeth and bony abnormalities can be easily detected on a single 
film (Walsh, 2010). It can also be used to help patients’ understand their dental 
condition. The current study showed that more than two-thirds of the respondents 
often/always took an OPG during the pre-radiation dental assessment. The frequency 
of taking other radiographs such as IOPAs and PBWs was less compared to OPG. There 
was a difference in the frequency of taking each type of radiographs between Malaysia 
and New Zealand which may be due to differences in treatment philosophies, 
resources or guidelines that has been used.   
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5.5.2 Multidisciplinary meetings for head and neck cancer patients 
 
Multidisciplinary team (MDT) care is considered as best practice for management of 
HNCa patients. MDM improved disease staging, encouraged allied health input and 
coordinated care (Friedland et al., 2011). Survival rate were significantly higher in OSCC 
patients who had been managed through a MDT care group compared to the non-MDT 
care group (Liao et al., 2016). However, further studies revealed that there was only 
minimal evidence that showed MDT care improves survival outcomes or local tumour 
control. It is unclear if MDT has an impact in patient experience or quality of life. The 
research demonstrated a limited degree of support for the positive impact of MDT 
meetings in oncology settings. The authors recommended that it was more sensible 
and cost effective to discuss particularly difficult or controversial cases, rather than the 
universal inclusion of all patients for MDT discussion (Pillay et al., 2016). From the 
dental point of view, it is noted that pre-treatment dental assessment and OPG 
imaging were performed more frequently in the MDT setting. This leads to 
comprehensive preventative dental education and extractions to reduce ORN risk. 
Adherence to dental recalls was enforced which led to a direct impact on patients’ 
quality of life post-radiotherapy treatment (Kelly et al., 2013). 
 
In this study, more than half of the respondents in both countries stated that MDM 
were available at their centres. It is postulated that these respondents were involved 
with MDM. MDM were mostly held at hospitals located in major cities and were more 
likely to have involvement of multiple specialities. With exception of radiation 
oncologists, ORL surgeons and dental practitioners, other allied health practitioners 
were distinctly more involved in New Zealand settings compared to Malaysia. This may 
be due to the greater availability of allied health practitioners in New Zealand which 
allows them to follow the protocols regarding the types of health practitioners that 
should be involved in MDM. However, there was not any hard and fast rule concerning 
the type of health practitioners that should be involved with MDM. 37.3% of the 
respondents that were not involved with MDM were more likely not to use any 
guidelines or were not aware of such guidelines. The number of health practitioners/ 
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specialities involved with MDM did not have any effect on compliance of the dentists 
towards using any guidelines. 
 
Focusing on the involvement of dental health professionals in MDM, a study was done 
in the United Kingdom to identify patient and carer unmet needs during consultation 
and review clinics. The dental ‘support services’ readily available at the time of 
consultation were as follows; dentist (44%), Oral Rehabilitation consultant (27%) and 
dental hygienist (26%) (Rogers et al., 2011). This showed more than half of the MDM 
did not have dental personnel readily available for consultation. The current study did 
not reflect readily available support services such as dentist and hygienist at the time 
of consultations or during MDM in both countries. Multiple guidelines have listed 
dentists as an integral part of the MDM team but it is questionable how often we as 
dentists are involved with MDM.  
 
Compared to other cancer-related management, majority of the dental treatments can 
be provided by any general dental practitioner in the private settings or hospital-based 
settings all over the country. It is not restricted only to the main cancer centre or major 
hospitals. This will be more cost effective and minimize the barriers to access. For 
patients that are at risk of specific complications, it is best to manage them at a 
tertiary care centre. It is recommended that hospital-based dentists should be involved 
in MDM when it is available at their centres to be acquainted with the general 
overview of the HNCa patients. If it is decided to refer these patients to their local 
dentist, all the important information such as radiotherapy regime and dosimetry 
should be conveyed to the dentists accepting these patients. This will save patients’ 
time, money and improve post-radiotherapy reviews. 
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5.5.3 Commencement of dental treatment for HNRT patients  
 
Removing oral foci that might cause problems during and after radiotherapy should be 
a priority when managing this group of patients. This study showed that almost all of 
the respondents would commence dental treatment at least two weeks before starting 
radiotherapy treatment. Only a small number of respondents would start dental 
treatment after radiotherapy. This decision probably related to multiple factors such as 
types of treatment needed (scaling, restorations vs extractions) and adequate time to 
complete needed care before starting radiotherapy. Dentists will aim to avoid delays 
to commencement of radiotherapy treatment due to incomplete dental treatment. 
There are still controversies regarding extractions post-radiotherapy and management 
is decided on a case-by-case basis. Therefore, the options are ether extractions prior to 
radiotherapy treatment or prescribing pentoxifylline and vitamin E if extractions are 
planned after radiotherapy treatment has started. 
 
Extractions of compromised teeth should be done at least two weeks before the start 
of radiotherapy (Schiødt and Hermund, 2002). This is to allow good wound healing and 
reduce the risk of ORN. Other non-urgent treatments such as scaling and restorations 
can be completed after patient is finished with radiotherapy treatment. Previous study 
mentioned that 74% of dentists saw patients for pre-radiation evaluation and 68% 
reported treating patients during HNRT (Patel et al., 2012). This study revealed that 
almost all of the respondents would commence treatment at least two weeks prior to 
the radiotherapy treatment. There were a small number of respondents that will 




5.5.4 Clinical guidelines for pre-radiation dental assessment in HNCa 
 
The need to develop evidence-based clinical guidelines for managing the dental needs 
of patients with HNCa is becoming more prominent. Our older population are retaining 
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more of their natural teeth, compared to previous generations. Globally, there has 
been an increase in the incidence of head and neck cancer in young adults (less than 
45 years old) (Hussein et al., 2017). This poses an increased threat of dental 
complications post-radiotherapy.  
 
Management of the dental needs were mainly based on clinical experience of 
individual clinicians rather than evidence-based guidelines. There is not any national 
accepted oral care protocols for cancer patients based upon research evidence (Barker 
et al., 2005). The protocols and guidelines have been discussed in section 2.8. 
Most of these national guidelines state the importance of the involvement of dental 
personnel as part of the MDM team. The Cancer Council of Australia specifically 
mentioned that Special Needs dentists should assess and be involved with the 
planning, treatment and follow-up of patients that are likely to have surgery or 
radiation to the mouth and jaws. Dental issues were not precisely addressed in 
majority of the national guidelines. Some of the guidelines outlined the recommended 
dental treatment and management but it was rarely a comprehensive list. Regular 
revision of guidelines is also crucial to make sure that the contents are up to date. 
 
As shown by our study, the majority of the Malaysian respondents (85%) were not 
aware of any such guidelines compared to New Zealand respondents (45.7%). 
Although 48.6% of the New Zealand respondents used some sort of guidelines, it was 
actually different for each centre. These included national guidelines from New 
Zealand and other countries, published articles, consensus statement and hospital 
protocols. The robustness of the content is something that we should think through. It 
may either be general recommendations for managing the dental needs or specific 
treatment of oral foci. The decision to retain or extract a tooth is multifactorial. It 
involves the patient’s general condition, comorbidities, motivation towards 
maintaining good oral health, tumour diagnosis, the dosimetry of radiation therapy 
and clinician’s knowledge and skills regarding this issue (Ben-David et al., 2007; Studer 
et al., 2011). The guidelines used by our respondents advocate preventative 
management such as fluoride regime and fabrication of fluoride trays. Few of the 
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resources supplied information on management of dry mouth and trismus. National 
guidelines are more general compared to journal articles. However, The Royal College 
of Surgeons of England / The British Society for Disability and Oral Health (2012) has 
developed a specific and comprehensive national guideline for the management of 
oral conditions in oncology patients requiring radiotherapy, chemotherapy and/or 
bone marrow transplantation. 
 
Most of these resources mentioned the importance of preventative treatments, dry 
mouth management and extractions. Ben-David et. al (2007) and Buglione et. al (2016) 
had outlined the types of tooth that needs to be extracted before starting 
radiotherapy treatment. It included teeth with non-restorable caries or caries that 
extended to the gum line, teeth with large, compromised restorations with significant 
periodontal attachment loss (pocketing >5 mm), and those with severe erosion or 
abrasion if they were in the parts of the jaws expected to receive a high dose (the 
posterior mandible and maxilla ipsilateral to the tumour and the posterior mandible 
contralateral to the tumour). Studer et. al (2011) mentioned that dental treatments 
depended on whether the problem was in a high risk area, intermediate- or low-risk 
area or an area with no radiation-specific risk. These risk areas would be marked by the 
radiation oncologist before referral being made to the dentist. It was comprehensive 
and presented in a table format which is user friendly.  
 
A task force in Italy had produced a consensus particularly relating to those statements 
with limited evidence available.  The topics covered were management of dental 
pathologies and ORN (Buglione et al., 2016), mucositis (De Sanctis et al., 2016)  and 
xerostomia and trismus  (Buglione et al., 2016). Definition, risk factors, assessment 
scale and dental treatment before, during and after radiotherapy were discussed in 
detail. The task force consisted of radiation oncologists, oncology physicians, oral care 
physicians, radiologists, and nurses. They discussed ways to minimize risk of ORN when 
considering extractions. Schuurhuis et al. (2015) had also identified significant oral foci 
of infection that should be either effectively treated or removed starting HNRT. Both 
papers specifically mentioned the types of oral foci that may be associated with 
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doubtful prognosis or were at risk of dental disease in the future (Figure 1 and Table 
2).  This can help dentists with the decision making and treatment planning for HNCa 
patients undergoing radiotherapy. 
 
Most of the resources provided specific fluoride regimes such as usage of high fluoride 
toothpaste (5000 ppm), fluoride mouthwashes and fluoride gels (1.1% neutral sodium 
fluoride). Remineralising products such as casein phosphopeptide–amorphous calcium 
phosphate (CPP–ACP) was also suggested as part of the preventative management. 
Management of trismus was only mentioned by some resources. This includes using 
wooden tongue depressors or a jaw motion rehabilitation system. Management of dry 
mouth included the use of saliva substitutes or saliva stimulants. Saliva substitute 
products mentioned were chamomile or sage rinse, Saliva Orthana, Biotene Oral 
Balance saliva replacement gel and BioXtra. Saliva stimulants include pilocarpine and 
chewing sugar-free chewing gum. Only two resources gave a comprehensive outline 
regarding this issue. 
 
The availability of comprehensive published guidelines showed the need to use 
protocols and guidelines in managing the dental needs of HNCa patients that will be 
undergoing radiotherapy treatment.  The current study highlighted the need for 
consistent evidence-based guidelines for each country. 
 
This study showed that consultants/specialists used guidelines more often compared 
to other dentists. GDP/dental officers usually were not aware of any guidelines. Among 
the consultants/specialists, SND specialists were the people who usually use guidelines 
in managing this group of patients followed by DPH/MComm graduates. It might be 
because SND specialists usually manage the dental needs of HNCa patients so it is 
possible that they were more aware of such guidelines. DPH/MComm graduates may 
have been involved with developing guidelines. On the other hand, OS/OMF surgeons’ 
management are more related to tumour resection compared to routine dental 
treatment. There was no relationship between the usage of guidelines for managing 
the dental needs of these patients and the types of advice or management provided by 
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the dentists. The management provided was similar whether the respondents used 
any guidelines or not. 
 
 
5.5.5 Knowledge and practice regarding the dental management of HNCa patients 
that will be undergoing HNRT 
 
Radiotherapy for head and neck cancer can cause significant oral complications as 
described in Section 2.4. In this study, the distribution of HNRT complications observed 
by our respondents in both countries was quite similar. Mucositis and xerostomia were 
the most common complications. The less common complications observed were 
osteoradionecrosis, trismus and candidiasis as complications of radiotherapy 
treatment. New Zealand respondents witnessed more caries/radiation caries in their 
patients compared to the Malaysian respondents. Other complications that had been 
observed include altered taste (dysgeusia), dysphagia and failing of existing heavily 
restored teeth or implants.  
 
The majority of the respondents in both countries would ‘often/always’ provide advice 
regarding oral hygiene practice (OHP), diet , lifestyle changes such as smoking 
cessation and reduce alcohol intake, side effects of HNRT, the importance of regular 
dental recalls and regular fluoride use. Providing information and educating the 
patients and their families about the side effects of radiotherapy treatment is vital for 
patient compliance and minimize oral complications (Schiødt and Hermund, 2002).  
The American Academy of Oral Medicine (2016) suggested patient’s participation to 
enhance their long-term oral health outcomes. Informing patients about the 
importance of dental recalls and compliance towards dental management post- 
radiotherapy was advocated along with advice to motivate them and identify if there 
were any barriers to access such as transportation, lack of health care experts and 




The use of high fluoride toothpaste (Duraphat 5,000 ppm) and daily alcohol-free 
fluoride mouthwash is recommended for HNRT patients (Jawad et al., 2015). One 
study noted that only 23% of dentists recommended topical fluoride therapy or other 
products/measures for patient starting HNRT (Patel et al., 2012). This includes fluoride 
products and fluoride trays for home usage. Our study showed 85% of Malaysian 
respondents and 94.3% of New Zealand respondents ‘often/always’ advised on regular 
fluoride use but only a small number would fabricate fluoride trays for home use 
(22.5% Malaysia, 8.6% New Zealand). Respondents that observed more radiation-
related dental caries among their HNCa patients were more likely to provide fluoride 
trays for home used. However, there was no relationship noted between the 
frequency of complications observed (xerostomia and caries/radiation caries) with 
others preventative management provided by the respondents.  
 
The New Zealand Guidelines Group (2009) did not recommend home use of fluoride 
gels because of the risk of ingesting excessive fluoride which may cause gastritis. The 
Expert Advisory Group agreed that fluoride gels should be professionally applied. 
Fluoride gels are available in a neutral sodium fluoride preparation and an acidulated 
phosphate fluoride preparation in New Zealand. In Malaysia, there was not any specific 
recommendation regarding at-home use of topical fluoride gel and trays. Casein 
phosphopeptide–amorphous calcium phosphate (CPP–ACP), added to patients daily 
oral care regimen will improve caries control in hyposalivation patients through 
increasing the acid resistance of the teeth and controlling cariogenic bacterial activity. 
Significant decreases in the incidence rates of soft lesions per patient and per root 
surface in a CPP-ACP group compared with a non-CPP-ACP group  has been noted 
(Katsura et al., 2016). 
 
This study also showed that almost all of the respondents from both countries 
‘never/sometimes’ fabricated mucosal guards/radiation stent. Only 5% of Malaysian 
dentists and 8.6% of NZ dentist ‘often/always’ provide mucosal guards or radiation 
stents. It coincided with a similar study that found only 11% of the dentists provided 
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mucosal guards (Patel et al., 2012). There are many types of radiation stents and 
mucosal guards, depending on clinician’s design as it can be custom-made. Ben-David 
et. al (2007) used polyvinyl siloxane putty as radiation guards and a 5-mm separation 
was intended between the metallic restorations and the soft tissue. Other appliance 
includes a mouth opener appliance. It is used to open patient’s mouth during external 
beam radiotherapy using linear accelerator to avoid exposure of the oral cavity. It is 
made of resin and disposable. It is cheap, easy to produce and easily cleaned. 
Fabrication of a mouth piece to reposition the patient during IMRT is also beneficial. 
The mouth piece will immobilize the patient’s head therefore decreasing head and 
neck rotation, flexion and extension. It can be made of thermoplastic splinting material 
and tray. Fabrication of a space retainer/spacer can prevent backscatter of amalgam 
restorations on CT scan images which can lead to incorrect radiotherapy treatment 
planning. It is made using a soft-type thermoflex material (Matsuzaki et al., 2017).  
 
Other types of advice provided were techniques of managing xerostomia, usage of a 
super soft toothbrush during the mucositis period, types of dental products to be used 
or avoid (such as alcohol mouthwashes) during and post HNRT and chlorhexidine 
mouthwash usage when required. Management of dry mouth includes frequent 
sipping of water, chewing sugar free gum and usage of oral lubricants, mouthwash and 
toothpaste specifically for dry mouth. A range of products include Oral 7 products, 
Biotene products and GC Dry mouth gel.  Specific advice related to the treatment plan 
was also discussed where applicable; antibiotic cover for invasive dental treatment, 
steroid cover and medication changes to manage bleeding risk. Some of the patients 
were provided with a written booklet about HNRT and dental contact information. 
 
There were not any statements regarding management related to mucositis in this 
study. Mucositis happened during radiotherapy treatment and we hypothesized that it 
was usually managed by the oncology nurse. Management of mucositis involved pre-
radiotherapy prevention modalities and monitoring progression of mucositis during 
the radiotherapy period as suggested by a recent consensus statement (De Sanctis et 
al., 2016). Previous studies stated multiple prevention and treatment strategies for 
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managing mucositis (Lalla et al., 2015; De Sanctis et al., 2016).  Prevention of mucositis 
before commencement of radiotherapy involved reinforcement of oral hygiene 
practice and professional plaque debridement or scaling to control periodontal 
disease. Advocating the use of a soft toothbrush and interproximal cleaning is also 
important. During the radiotherapy treatment period, it is advisable to re-evaluate the 
patient’s oral hygiene and assess mucositis progression. The use of non-alcohol 
mouthwash during this period is important, especially when patients are unable to 
brush due to pain. Saline or sodium bicarbonate mouthwash can also be used to 
maintain oral cleanliness. There is the possibility that benzydamine mouthwashes can 
be used to prevent radiation-induced mucositis in HNCa receiving moderate-dose 
radiation therapy (up to 50 Gy) without chemotherapy (Epstein et al., 2001). A 
randomized double-blind study was done which revealed a reduction of erythema and 
ulceration in the benzydamine group compared to the placebo group in patients 
treated with a radiotherapy cumulative dose of 50 Gy (Epstein et al., 2001). 
 
There is lack of evidence saying that one type of mouthwash is superior to the other. 
MASCC/ISOO had additional recommendations for the management of mucositis. The 
panel suggested that 0.2% morphine mouthwash might provide pain relief secondary 
to oral mucositis in HNCa patients receiving chemoradiation therapy.  They also 
recommended that oral zinc supplements administered orally may be beneficial to 
prevent oral mucositis in oral cancer patients receiving radiation therapy or 
chemoradiation therapy. 
 
The consensus statement also discussed the practices that are not recommended for 
prevention and management of oral mucositis in HNRT patients. Cryotherapy is not 
recommended during (chemo) radiation even though it was found to be beneficial in 
patients receiving bolus 5-fluorouracil or high dose melphalan. It can cause decrease in 
tissue oxygenation. Amifostine is not recommended in patients receiving 
chemoradiotherapy for HNCa because it has many side effects and is also expensive. 
The following topical agents are not recommended for mucositis prevention and 
treatment; barrier agents (sucralfate, GelClair, MuGard and Mucotrol), allopurinol gel, 
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chlorhexidine mouthwash, povidone-iodine , triclosan mouth washes, iseganan mouth 
washes, aloe vera, Granulocyte macrophage colony-stimulating factor, pure natural 
honey, Misoprostol and Prostaglandin E2, antibiotic and antifungal pastilles. Systemic 
continuous practice of steroidal therapy for mucositis prevention/treatment is not 
recommended. The consensus stated that there is no recommendation regarding the 
use of Low Level Laser Therapy to reduce mucositis.  
 
This study did not reveal any findings regarding mucositis management in terms of 
advice, prevention and treatment modalities from any of the respondents. Even 
though mucositis is the most common and acute side effect of radiotherapy and the 
protocols for management of mucositis are well established, it is possible that the 
result of this study may support the hypothesis that mucositis was usually managed by 
the oncology nurse rather than the dental team. 
 
Although there was a low incidence of trismus reported in this study, trismus may be 
managed by daily mouth exercises. The easiest and cheapest way of doing jaw exercise 
is using increasing numbers of wooden tongue depressors as a bite block. There are 
also devices readily available to help with the management of trismus such as 
TheraBite Jaw Motion Rehab System and OraStretch Press Jaw Motion Rehab System. 
Both are handheld devices and proven to be more effective than using wooden tongue 
depressors. The kit consisted of the device, a patient log, foam bite pads and 
measuring scales. It can be used by both dentate and edentulous patients. The device 
uses passive motion to stretch the user's jaw, joint and facial tissues for increased 
mobility, flexibility, and function. Patients can gain 1-2mm increase of opening per 
week. Management of trismus relies heavily on the patient’s commitment and 
compliance towards treatment. The importance of dental recalls after radiotherapy 
treatment should be emphasized during these assessments. It is a lifelong commitment 
to minimise HNRT side effects on oral environment.  
 
During the pre-radiation dental assessment, it is prudent to discuss ORN risk and ways 
to minimize it. A small percentage of the respondents stated that they had 
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encountered patients with ORN previously. ORN is not only caused by extractions after 
commencement of radiotherapy, but it can also be due to traumatic injury from sharp 
teeth edges or ill-fitting dentures. ORN can also be spontaneous. The theory of 
pathogenesis of ORN by Marx (1983) described ORN as the result of tissue hypoxia, 
hypocellularity and hypovascularity. The hyperbaric oxygen therapy (HBOT) discussed 
the concept of creating different oxygen gradient between blood and tissue by 
increasing the oxygen level in the blood. Consequently, it will enhance the diffusion of 
oxygen into hypoxic tissue. The increased oxygen supply stimulates fibroblast 
proliferation, angiogenesis and collagen formation. The usage of HBO as a preventive 
measure and also treatment modalities of ORN is still controversial and inconclusive. It 
is usually promoted as an adjunctive therapy in management to ORN. A systemic 
review of 19 articles revealed that while prophylactic HBO therapy appeared to reduce 
the risk of developing ORN after tooth extractions, the conclusions were ‘based on 
weak evidence’ (Nabil and Samman, 2011). Another recent study recommended that 
HBOT can be used for  stage I and II ORN and for selected cases of stage III ORN 
(Dieleman et al., 2017). Other factors that should be considered when proposing the 
usage of HBO is high treatment cost, the burden of time and logistics and also 
disruption to patient’s daily routine (Ceponis et al., 2017). 
 
Delanian and Lefaix (2004) proposed a new theory for the pathogenesis of ORN. They 
stated that bone damaged by radiation is mainly the result of radiation-induced 
fibrosis. This led to the development of a double or triple-drug therapy to reduce 
radiation-induced fibrosis and bone destruction and to stimulate osteogenesis via an 
antioxidant pathway. Treatment with pentoxifylline combined with tocopherol 
with/without clodronate led to complete recovery in most patients at 6 months. 
Pentoxifylline and tocopherol (Vitamin E), in combination, can work synergistically to 
regress ORN and when used prophylactically, reduced the incidence of post-extraction 
ORN from 5% to 1.2% (Patel et. al, 2016). The patient has to start taking the regime 
one month before extraction and continue until healing is complete or another option 
is to start three months before extraction and continue for three months post 
extraction. A combination of pentoxifylline, tocopherol/vitamin E, and clodronate 
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known as PENTOCLO protocol has shown promise in the treatment of refractory ORN 
despite the lack of a prospective randomised controlled trial (Lyons and Brennan, 
2017). 
 
In summary, there are multiple published protocols regarding the prevention and 
management of oral complications related to HNRT. The consensus statements by the 
Italian task force as discussed in section 5.5.4 are considered as the most 
contemporary and comprehensive protocols which bring together recommendations 
of various guidelines/protocols. The consensus statements are accepted by most 
international authorities. These consensus statements should serve well as a basis for 
ongoing development of guidelines and protocols.  
 
 
5.5.6 Adequacy of dental training  
 
In this study, we specifically asked whether respondents felt that their undergraduate 
and postgraduate training (if applicable) was adequate to manage HNCa patients that 
would be undergoing radiotherapy treatment. Our results showed that there were 
different responses regarding adequacy of undergraduate training between the two 
countries. 65% of Malaysian respondents mentioned that they had adequate 
undergraduate training while only 17.1% of the New Zealand respondents gave the 
same response. The majority of the consultants/specialists and specialist trainees 
responded that they had adequate postgraduate training. There was an association 
between the level of training and the level of work experience. 51.7% of New Zealand 
respondents with extensive work experience (more than 15 years) mentioned that 
they did not have adequate undergraduate training compared to only 14.3% of 
Malaysian respondents from the same group. This suggested that the undergraduate 
training of more than 15 years ago was inadequate. The total percentage of perceived 
inadequate undergraduate training for the group with low to moderate work 




It is possible that this subject is not the main focus of the dental curricula. Inclusion of 
topics such as side effects of HNRT on the oral environment, preventive management 
and management of HNRT complications in the oral cavity will empower future 
dentists in managing the dental needs of HNCa patients. This will improve access to 
care and benefit the patients in multiple aspects. Hospital-based dentists will be 
expected to treat complex patients and act as a support system for the general dental 
practitioner in managing HNCa patients. 
 
The socio-demographic profile of this study showed that there were more New 
Zealand respondents with a high level of work experience involved with this study 
compared to Malaysian respondents. The majority of Malaysian respondents had a low 
to moderate level of work experience. Interestingly, the majority of the older 
generation of dentists/specialists in New Zealand felt that they had inadequate 
undergraduate training compared to Malaysia where the same responses were more 
common in the younger generation. It is possible that the less experienced clinicians 
have not been exposed to enough cases to judge whether the training was adequate. 
However, it has to be acknowledged that nearly half (48.2%) of New Zealand’s younger 
generation of dentists felt that they had inadequate undergraduate training in this 
area. We did not ask respondents which university they graduated from but the 
majority of New Zealand dentists were assumed to have graduated from the University 
of Otago, which is the only dental school in New Zealand.  In Malaysia, the dental 
graduates were more diverse as they might be a graduate of local or international 
dental school. There are nine institutions that offer dental degree courses in Malaysia 
alone. Multiple literature reviews have recommended re-evaluation of current 
undergraduate curricula and organization of postgraduate courses to incorporate more 
information about the dental management of oncology patients pre-, peri- and post-
radiotherapy (Güneri et al., 2008; Alpöz et al., 2013).   
 
More than half of the respondents recommended further training as one of the main 
suggestions for improvement, particularly by younger dentists and dentists with 
limited work experience. Continuing education for dentists regarding the dental 
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management of these patients can be valuable (Alpoz et. al 2013; Patel et. al 2012). 
From our study, two-third of the respondents from both countries stated that they had 
not attended any related courses in the past three years. 82.5% of Malaysian 
respondents and 71.4% of New Zealand respondents felt that they needed to attend 
courses or have further training with regards to this topic.  Oral complications can be 
efficiently managed if the dental health professional constantly updates their 
knowledge related to this subject. It should focus on cancer therapy, its oral 
complications and prevention and management options (Hancock et al., 2003). It is 
uncertain if such courses are available in both countries. 
  
 
5.5.7 Barriers in providing dental care for HNCa patients that will be undergoing 
radiotherapy treatment 
 
Previous studies have noted that inadequate time to provide dental treatment before 
starting HNRT is the barrier to effective treatment (81%) while lack of 
training/knowledge required to adequately treated the patients only scored 10% (Patel 
et al., 2012). The majority of the respondents from both countries noted that the main 
barrier in managing the dental needs of these patients was lack of time. The moderate 
and highly experienced group of dentists preferred to have more time allocated or to 
be released from other duties to enhance the provision of care provided to this 
particular group of patients. Lack of time may also mean inadequate time to make sure 
that patients are orally fit before undergoing radiotherapy due to late referrals. 
 
The problems faced by respondents in both countries were similar except for lack of 
funding which was more prominent in New Zealand. Apart from the issues that has 
been stated before such as lack of clinical guidelines, inadequate training of dentists or 
specialists, late referrals and low quality of referrals from the medical team, we 
managed to identify other obstacles in managing this group of patients. These were 
lack of time, lack of awareness from the medical team and poor communication 




We hypothesise that lack of awareness among the medical teams regarding the 
importance of dental management for these patients was the cause for late referrals 
and low quality of referrals. A study in the United States noted that 25% of radiation 
oncologists reported inadequate knowledge of how to treat patients with oral health 
complications due to head and neck radiotherapy and 67% of the radiation oncologists 
were keen to attend continuous education in this topic (Patel et al., 2012). The current 
study indicated that there was a need for continuing education for radiation 
oncologists regarding effective oral and dental management of patients receiving 
radiotherapy to the head and neck region. Educating the medical team in relation to 
early and quality referrals will also give positive impacts on patient’s pathway of care. 
The target group should be radiation oncologists and ORL specialists, but should also 
include other groups of health professionals such as oncology nurse and head and neck 
cancer coordinator. 
 
Lack of patient awareness, lack of self-dental care and refusal of care can be 
challenging. Lack of patient awareness regarding the importance of dental care may 
lead to non-attendance to dental appointment before or after radiotherapy treatment.  
This current study suggested that we should improve patient education in relation to 
the importance of dental care post-radiotherapy. The use of a log book to maintain 
continuity of information in cancer care should be considered (van Wersch et. al, 
1997). The logbook can convey information to patients about the overall management 
of HNCa. Information should include the importance of good oral health and related 
advice on the management of radiotherapy-related oral complications and the need 
for frequent recalls. Optimistically, this may improve patient’s adherence to care. 
 
Lack of communication between dentists, radiation oncologists and their patients 
might cause  lack of coordination of care and treatment delay (Lawrence et al., 2013). 
When HNCa patients required treatment from multiple disciplines only 35% of visits 
were coordinated with other specialties that were also providing care (Fletcher et. al, 
1984). There might be circumstances where patients had to be seen by a local hospital-
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based dentist prior to their radiotherapy treatment or return to care after completion 
of radiotherapy.  Patients could also be dentally managed at one centre pre-
radiotherapy and by another centre post-radiotherapy. If this is the case, good 
communication should be established between the dentist in the main cancer centre 
and the local dentist.  
 
 
5.5.8 Future research 
 
Future research in relation to dental management of head and neck cancer patients 
should include audits investigating ways to improve the delivery of care.  Examples of 
questions that need to be explored include assessing the number of HNCa patients 
referred for dental assessments prior to radiotherapy, radiation information that is 
being provided upon referral and prevalence of HNCa patients attending dental follow 
up post radiotherapy. General research topics could include comparison studies of 
knowledge and awareness between dentist and medical personnel regarding pre-
radiation dental assessment, validation of available dental assessment tools used for 
pre-radiation dental assessment and evaluation of the dental curricula regarding 
dental management of HNRT patients. Specific research topic may be related to the 
dental treatment provided for these patients such as comparison of different fluoride 
treatment regimes, fabrication and compliance of radiation stents/mucosal barriers 
usage and use of the PENTOCLO protocol as an alternative to hyperbaric oxygen for 







6. CONCLUSION  
 
This research project provided an overview of how dental care for patients treated 
with radiotherapy for HNCa was carried out. The study demonstrated that there were 
significant differences between the two countries in certain area of management. 
Surprisingly, some of the practices and outcomes were remarkably similar. Despite the 
strong need for clinical guidelines in managing the dental needs of these patients, 
there was no failure of service provisions. This research indicated that some dentists 
working in the field perceived gaps in their knowledge and in decision making when 
planning dental treatment for HNCa patients who will be undergoing radiotherapy. 
Thus, the findings can be incorporated into undergraduate and postgraduate 
programmes and orientation programmes for dental house surgeons, registrars, dental 
officers and those undertaking hospital attachments. It will also be used to provide 
continuing dental education for general and specialist dental practitioners. It is 
anticipated that it will lead to the development of a comprehensive national protocol 
to manage the patients’ dental needs, particularly in terms of workflow interactions 
between radiation oncologists, oral and maxillofacial surgeons, special care dentists 
and other members of the dental care team. Improvement in communication between 
patients and health professionals will enhance the delivery of care. Our role as dental 
professionals should also include educating patients and the medical team, especially 
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PARTICIPANT INFORMATION SHEET 
Study title: Awareness of pre-radiation dental assessment of head and neck 
cancer among dentists in Malaysia and New Zealand 
Principal 
investigator: 
Name: Professor Alison Rich 
Department: Sir John Walsh Research 
Institute 
Contact phone number: 
03 4795686 
 
Thank you for showing an interest in this project.  Please read this information sheet carefully 
before deciding whether or not to participate.  If you decide to participate we thank you.  If 
you decide not to take part there will be no disadvantage to you and we thank you for 
considering our request. Completion of the form indicates consent to participate in the study. 
 
Aim of the project 
The purpose of this project is to investigate the practices of dentists when treating head and 
neck cancer patients who are about to undergo radiotherapy.  
 
What types of participants are being sought? 
We are seeking dentists who are working in a hospital setting in New Zealand and Malaysia, 
including general dentist and specialist.  
 
What will participants be asked to do? 
Should you agree to take part in this project, you will be asked to answer a questionnaire 





What data or information will be collected and what use will be made of it? 
The data collected may contain some personal information such as your position and 
specialisation. Your confidentiality will be maintained at all times and no information that 
might identify you will be used in any reports from this research.  
 
Data collected will be securely stored and will only be accessed by the research team at Otago 
University. Data obtained as a result of the research will be retained for at least 5 years in 
secure storage. Any personal information held on the participants may be destroyed at the 
completion of the research even though the data derived from the research will, in most cases, 
be kept for much longer or possibly indefinitely. 
 
The results of the project may be published and will be available in the University of Otago 
Library (Dunedin, New Zealand). Should you be interested in the results of this study, we will 
send you a copy of the results on conclusion of the study. 
 
This project is being undertaken as part of Adlin Suhaimi’s requirements for the Doctor of 
Clinical Dentistry (DClinDent) course. 
 
Any questions? 
If you have any questions now or in the future, please feel free to contact either: 
Name: Professor Alison Rich 
Position: Principal Investigator 
Department: Sir John Walsh Research Institute 
Contact phone number: 
03 4795686 
alison.rich@otago.ac.nz 
Name: Adlin Suhaimi 
Position: Student Investigator 
Department: Sir John Walsh Research Institute 
Contact phone number: 
 03 4797046 
suhad145@student.otago.ac.nz 
 
This study has been approved by the University of Otago Human Ethics Committee (Health) 
H16/068. If you have any concerns about the ethical conduct of the research you may contact 
the Committee through the Human Ethics Committee Administrator (phone +64 3 479 8256 or 
email gary.witte@otago.ac.nz). Any issues you raise will be treated in confidence and 
investigated and you will be informed of the outcome. 
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8.6 Research Questionnaire (Malaysia) 
 
RESEARCH QUESTIONAIRE (MALAYSIA) 
Pre-Radiation Dental Assessment of Head and Neck Cancer Patients 
Instructions: Please answer the following questions, tick in the circles or write on the lines when applicable. 
1. What is your sex? 
  Male 
  Female 
2. What is your ethnicity? 
  Malay   Indigenous (please specify):___________________ 
  Chinese   Others (please specify):______________________ 
  Indian 
3. What is your current position?  
  Consultant/specialist (please specify):_______________________________ 
  Specialist trainee (please specify):__________________________________ 
  Dental officer 
  First year dental officer 
  Other (please specify):___________________________________________  
4. Where do you currently practise dentistry? 
  Country:__________________________________________ 
 City:_____________________________________________ 
 Department:_______________________________________ 
5a. How long have you worked as a dentist? ________ years 
  b. How long have you worked in hospital-based dental practise? ________ years 
6. How many hours per week do you currently work in hospital-based dental practise? ___________ hours 
 
7. Please estimate the average number of head and neck cancer patients that you see prior to them  
undergoing radiotherapy per year. ________ (number) 
 
8. Do you routinely take radiographs during these assessments? 
    Never         Sometimes  Often  Always 
        (less than 50%      (more than 50% 
      of the time)            of the time) 
 
  Intraoral periapicals (IOPA):   
 Posterior bitewings (PBWs): 
 Orthopantomogram (OPG): 





9. Does your schedule allow for regular or fixed timeslots for assessment of these patients? 
Yes  No  I am unsure 
 
10. Who refers these patients to your centre for pre-radiation dental assessment? (Tick all that apply) 
Radiation oncologist  
Medical officer  
General dental practitioners 
Others (please specify):___________________________________ 
 
11. In cases where a patient was referred by a radiation oncologist, how frequently do you receive the 
information regarding the location, types and dosage of radiation that they might use? 
Never                Sometimes     Often   Always  Not Applicable 
            (less than 50%      (more than 50% 
         of the time)            of the time) 
 
 
12a. Are multidisciplinary clinics/meetings held at your centre to discuss the overall treatment plans for head    
and neck cancer patients? 
Yes  
No 
I am unsure 
 
    b. If yes, what other health practitioners are involved in these sessions? (You may tick more than one) 
Radiation oncologist 
Othorhinolaryngologist (ORL) 




Clinical specialist nurse 
Head and neck cancer co-ordinator 
Others (please specify):__________________________________ 
Not Applicable 
 
13. Do you follow a clinical guideline for pre-radiation dental screening of head and neck cancer patients?  
Yes (Please specify the guideline you follow) 
 Title/Author/Year:_____________________________________________ 
 No, I am aware of a guideline but do not follow it  
 (Please specify reason):__________________________________________ 




14. When would you normally commence dental treatment of a patient receiving radiotherapy?  
At least 2 weeks before radiation therapy 
Less than 2 weeks before radiation therapy 
During the radiation therapy period 
After radiation therapy is completed 
It does not matter 
 
15. In your experience, at what frequency do the following oral complications arise following radiation therapy 
to the head and neck?  
    Never                Sometimes  Often           Always 
           (less than 50%      (more than 50% 








g) Other condition (please specify): 
_________________________________ 
 
16. What management or advice do you provide during pre-radiation dental assessment for these patients? 
    Never                Sometimes  Often           Always 
           (less than 50%      (more than 50% 
        of the time)            of the time) 
 
a) Evaluation and reinforcement  
of oral hygiene practice 
b) Diet analysis and advice 
c) Advice on lifestyle changes (smoking 
cessation, reduce alcohol intake) 
d) Side effects of radiation therapy 
e) Importance of regular dental recall 
f) Regular fluoride use 
g) Fabrication of fluoride trays to be used 
at home 
h) Fabrication of mucosal guards  
or radiation stents 
 





17. Please tick the statement(s) below that apply to you. (You may select more than one) 
          Yes   No      Not Applicable 
a) I received adequate undergraduate training for providing appropriate  
dental care to head and neck radiation therapy patients 
b) I received adequate postgraduate training for providing appropriate 
dental care to head and neck radiation therapy patients 
c) I need to attend courses to update my knowledge of appropriate  
dental care for head and neck radiation therapy patients 
d) I have attended a continuing education course on pre-radiation 
dental assessment of head and neck cancer patient in the last 3 years 
  
18. In your opinion, what are the obstacles/problems that you face in providing dental treatment for patients 
about to receive radiation therapy? (You may tick more than one) 
  Lack of time 
  Lack of funding 
  Lack of appropriate facilities 
  Other (please specify):____________________________________________ 
 
19. In your opinion, what steps could be taken to enhance your ability to provide appropriate and timely dental 
treatment for patients about to receive radiation therapy? (You may tick more than one) 
  Further training 
  Financial support 
  Time/being released from other duties 
  Other (please specify):___________________________________________ 
  
20. Please use the space below to write any further comments/suggestions you may have regarding this 
research, or ways to improve the delivery of dental care to head and neck cancer patients that are about to 













8.7 Research Questionnaire (New Zealand) 
RESEARCH QUESTIONNAIRE (New Zealand) 
Pre-Radiation Dental Assessment of Head and Neck Cancer Patients 
 
Instructions: Please answer the following questions, tick in the circles or write on the lines when applicable. 
1. What is your sex? 
  Male 
  Female 
 
2. What is your ethnicity? (Please tick all that apply to you) 
  European      Samoan   Tokelauan   Indian 
  New Zealand European    Cook Island Maori  Other Pacific People  Other Asian 
  Other European     Tongan    Asian   Latin America 
  Māori      Niuean   Southeast Asian  African 
  Pacific people     Fijian   Chinese   Middle Eastern 
  Others (please specify):______________________________       
        
3. What is your current position?  
  Consultant/specialist (please specify):_______________________________ 
  Specialist trainee (please specify):__________________________________ 
  General dentist 
  House surgeon 
  Other (please specify):___________________________________________  
 
4. Where do you currently practise dentistry? 




5a. How long have you worked as a dentist? ________ years 
  b. How long have you worked in hospital-based dental practise? ________ years 
 
6. How many hours per week do you currently work in hospital-based dental practise? ___________ hours 
 
7. Please estimate the average number of head and neck cancer patients that you see prior to them 
undergoing radiotherapy per year. ________ (number) 
 
8. Do you routinely take radiographs during these assessments? 
    Never         Sometimes  Often  Always 
         (less than 50%            (more than 50% 
      of the time)                   of the time) 
 
  Intraoral periapicals (IOPA):   
 Posterior bitewings (PBWs): 
 Orthopantomogram (OPG): 




9. Does your schedule allow for regular or fixed timeslots for assessment of these patients? 
Yes  No  I am unsure 
 
10. Who refers these patients to your centre for pre-radiation dental assessment? (Tick all that apply) 
Radiation oncologist  
General medical practitioners 
General dental practitioners 
Others (please specify):___________________________________ 
 
11. In cases where a patient was referred by a radiation oncologist, how frequently do you receive the 
information regarding the location, types and dosage of radiation that they might use? 
Never                Sometimes     Often   Always  Not Applicable 
            (less than 50%             (more than 50% 
         of the time)                   of the time) 
 
 
12a. Are multidisciplinary clinics/meetings held at your centre to discuss the overall treatment plans for head    
and neck cancer patients? 
Yes  
No 
I am unsure 
 
    b. If yes, what other health practitioners are involved in these sessions? (You may tick more than one) 
Radiation oncologist 
Othorhinolaryngologist (ORL) 




Clinical specialist nurse 
Head and neck cancer co-ordinator 
Others (please specify):__________________________________ 
Not Applicable 
 
13. Do you follow a clinical guideline for pre-radiation dental screening of head and neck cancer patients?  
Yes (Please specify the guideline you follow) 
 Title/Author/Year:_____________________________________________ 
 No, I am aware of a guideline but do not follow it  
 (Please specify reason):__________________________________________ 







14. When would you normally commence dental treatment of a patient receiving radiotherapy?  
At least 2 weeks before radiation therapy 
Less than 2 weeks before radiation therapy 
During the radiation therapy period 
After radiation therapy is completed 
It does not matter 
 
15. In your experience, at what frequency do the following oral complications arise following radiation therapy 
to the head and neck?  
    Never                Sometimes  Often           Always 
           (less than 50%           (more than 50% 








n) Other condition (please specify): 
_________________________________ 
 
16. What management or advice do you provide during pre-radiation dental assessment for these patients? 
    Never                Sometimes  Often           Always 
           (less than 50%           (more than 50% 
        of the time)                 of the time) 
 
j) Evaluation and reinforcement  
of oral hygiene practice 
k) Diet analysis and advice 
l) Advice on lifestyle changes (smoking 
cessation, reduce alcohol intake) 
m) Side effects of radiation therapy 
n) Importance of regular dental recall 
o) Regular fluoride use 
p) Fabrication of fluoride trays to be used 
at home 
q) Fabrication of mucosal guards  
or radiation stents 
 








17. Please tick the statement(s) below that apply to you. (You may select more than one) 
          Yes   No      Not Applicable 
e) I received adequate undergraduate training for providing appropriate  
dental care to head and neck radiation therapy patients 
f) I received adequate postgraduate training for providing appropriate 
dental care to head and neck radiation therapy patients 
g) I need to attend courses to update my knowledge of appropriate  
dental care for head and neck radiation therapy patients 
h) I have attended a continuing education course on pre-radiation 
dental assessment of head and neck cancer patient in the last 3 years 
  
18. In your opinion, what are the obstacles/problems that you face in providing dental treatment for patients about to 
receive radiation therapy? (You may tick more than one) 
  Lack of time 
  Lack of funding 
  Lack of appropriate facilities 
  Other (please specify):____________________________________________ 
 
19. In your opinion, what steps could be taken to enhance your ability to provide appropriate and timely dental treatment 
for patients about to receive radiation therapy? (You may tick more than one) 
  Further training 
  Financial support 
  Time/being released from other duties 
  Other (please specify):___________________________________________ 
  
20. Please use the space below to write any further comments/suggestions you may have regarding this 
research, or ways to improve the delivery of dental care to head and neck cancer patients that are about to 












Please place this questionnaire in the reply-paid envelope and return to the investigators. Thank you.
 
 
 
